[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 417
1. McKinsey RD, Moritz CH, Meyerand ME, Tomé WA: Assessment of multiple task activation and reproducibility in patients with benign and low-grade neoplasm. Technol Cancer Res Treat; 2010 Aug;9(4):319-26
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Assessment of multiple task activation and reproducibility in patients with benign and low-grade neoplasm.
  • Twenty-four patients with proven benign and low-grade brain neoplasms each performed two iterations of four fMRI paradigms: language (word generation), primary and association auditory (text listening), upper limb fine motor control (alternating-limb bilateral finger tapping), and primary visual perception (reversing checkerboard).

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neurosurgery. 1996 Feb;38(2):329-38 [8869061.001]
  • [Cites] Comput Biomed Res. 1996 Jun;29(3):162-73 [8812068.001]
  • [Cites] AJNR Am J Neuroradiol. 1997 Sep;18(8):1529-39 [9296196.001]
  • [Cites] Magn Reson Imaging. 1998;16(2):105-13 [9508267.001]
  • [Cites] Neuroimage. 1998 Oct;8(3):249-61 [9758739.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1152-7 [16024896.001]
  • [Cites] AJNR Am J Neuroradiol. 2006 Apr;27(4):938-44 [16611797.001]
  • [Cites] J Neurol. 2006 Apr;253(4):471-6 [16283098.001]
  • [Cites] J Magn Reson Imaging. 2006 Jun;23(6):808-15 [16649200.001]
  • [Cites] Head Face Med. 2006;2:20 [16817959.001]
  • [Cites] Neuropsychol Rev. 2007 Jun;17(2):145-55 [17484055.001]
  • [Cites] AJNR Am J Neuroradiol. 2008 Mar;29(3):528-35 [18184849.001]
  • [Cites] Med Phys. 2000 Jul;27(7):1563-72 [10947259.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9718-23 [10931954.001]
  • [Cites] AJNR Am J Neuroradiol. 2002 Jun-Jul;23(6):1030-7 [12063237.001]
  • [Cites] J Neurosurg. 2002 Jul;97(1):21-32 [12134916.001]
  • [Cites] AJNR Am J Neuroradiol. 2003 Apr;24(4):652-7 [12695198.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Dec;87(24):9868-72 [2124706.001]
  • [Cites] Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5951-5 [1631079.001]
  • [Cites] Radiology. 1994 Jan;190(1):85-92 [8259434.001]
  • [Cites] AJNR Am J Neuroradiol. 1997 Aug;18(7):1317-22 [9282862.001]
  • (PMID = 20626198.001).
  • [ISSN] 1533-0338
  • [Journal-full-title] Technology in cancer research & treatment
  • [ISO-abbreviation] Technol. Cancer Res. Treat.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA109656; United States / NCI NIH HHS / CA / R01 CA109656-03; United States / NINDS NIH HHS / NS / 1F31NS5297-01; United States / NCI NIH HHS / CA / R01-CA109656
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS216845; NLM/ PMC2906819
  •  go-up   go-down


2. Sanatkumar S, Rajagopalan N, Mallikarjunaswamy B, Srinivasalu S, Sudhir NP, Usha K: Benign fibrous histiocytoma of the distal radius with congenital dislocation of the radial head: a case report. J Orthop Surg (Hong Kong); 2005 Apr;13(1):83-7
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign fibrous histiocytoma of the distal radius with congenital dislocation of the radial head: a case report.
  • Benign fibrous histiocytoma is such a rare tumour that only a few cases have been reported in the literature.
  • A patient with an apparently benign lesion of the distal radius, along with congenital dislocation of the radial head, was presented at St. John's Medical College Hospital in Bangalore, India.
  • In this case report, we review similar cases in the literature and discuss an unusual association with congenital dislocation of the radial head.
  • [MeSH-major] Amputation. Bone Neoplasms / surgery. Histiocytoma, Benign Fibrous / surgery. Neoplasm Recurrence, Local / surgery. Orthopedic Procedures / adverse effects

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15872408.001).
  • [ISSN] 1022-5536
  • [Journal-full-title] Journal of orthopaedic surgery (Hong Kong)
  • [ISO-abbreviation] J Orthop Surg (Hong Kong)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


3. Baghi M, Mack MG, Wagenblast J, Hambek M, Rieger J, Bisdas S, Gstoettner W, Engels K, Vogl T, Knecht R: Iron oxide particle-enhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: how reliable are the results? Anticancer Res; 2007 Sep-Oct;27(5B):3571-5
Hazardous Substances Data Bank. HEMATITE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Iron oxide particle-enhanced magnetic resonance imaging for detection of benign lymph nodes in the head and neck: how reliable are the results?
  • AIM: To evaluate the accuracy of ultrasmall paramagnetic iron oxide (USPIO: Sinerem)-enhanced MRI in patients with head and neck cancer and enlarged lymph nodes compared with current staging examinations using histology as a gold standard.
  • PATIENTS AND METHODS: Seventeen patients with a histologically proven squamous cell cancer of the head and neck (SCCHN) and different N-stages underwent a non-enhanced and a USPIO-enhanced MRI examination.
  • [MeSH-major] Ferric Compounds / metabolism. Head and Neck Neoplasms / diagnosis. Lymph Nodes / pathology. Magnetic Resonance Imaging / methods
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Middle Aged. Neoplasm Staging

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • Hazardous Substances Data Bank. FERRIC OXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17972519.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Ferric Compounds; 1K09F3G675 / ferric oxide
  •  go-up   go-down


Advertisement
4. Goh BK, Ooi LL, Kumarasinghe MP, Tan YM, Cheow PC, Chow PK, Chung YF, Wong WK: Clinicopathological features of patients with concomitant intraductal papillary mucinous neoplasm of the pancreas and pancreatic endocrine neoplasm. Pancreatology; 2006;6(6):520-6
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathological features of patients with concomitant intraductal papillary mucinous neoplasm of the pancreas and pancreatic endocrine neoplasm.
  • BACKGROUND/AIMS: The occurrence of concomitant pancreatic endocrine neoplasm (PEN) and intraductal papillary neoplasm (IPMN) of the pancreas has rarely been reported.
  • The median size of the endocrine neoplasms was 14 mm (range 2-30) and they occurred in the head (n = 3), body (n = 2) and tail (n = 5).
  • Seven of the PENs were classified as benign, 2 were potentially malignant, and 1 was frankly malignant with lymph node involvement.
  • The IPMNs were found in the tail (n = 4), head (n = 3), head and body (n = 1), body (n = 1) and the entire pancreas (n = 1).
  • Five of these neoplasms were benign, 2 were borderline and 3 were malignant (1 carcinoma in situ).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2006 S. Karger AG, Basel and IAP.
  • (PMID = 17124434.001).
  • [ISSN] 1424-3903
  • [Journal-full-title] Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
  • [ISO-abbreviation] Pancreatology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Chromogranins; 0 / Synaptophysin
  •  go-up   go-down


5. Eversole R, Su L, ElMofty S: Benign fibro-osseous lesions of the craniofacial complex. A review. Head Neck Pathol; 2008 Sep;2(3):177-202
MedlinePlus Health Information. consumer health - Paget's Disease of Bone.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign fibro-osseous lesions of the craniofacial complex. A review.
  • Benign fibro-osseous lesions of the craniofacial complex are represented by a variety of disease processes that are characterized by pathologic ossifications and calcifications in association with a hypercellular fibroblastic marrow element.
  • [MeSH-minor] DNA, Neoplasm / analysis. Humans. Mutation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Med Genet A. 2006 Dec 1;140(23):2646-706 [17103447.001]
  • [Cites] Eur J Endocrinol. 2006 Dec;155(6):839-43 [17132753.001]
  • [Cites] J Bone Miner Res. 2006 Dec;21 Suppl 2:P120-4 [17229000.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Jul;94(1):111-4 [12193904.001]
  • [Cites] N Engl J Med. 2002 Nov 14;347(20):1622-3; author reply 1622-3 [12432053.001]
  • [Cites] J Craniofac Surg. 2002 Nov;13(6):765-8 [12457091.001]
  • [Cites] Eur Radiol. 2002 Dec;12 Suppl 3:S109-13 [12522617.001]
  • [Cites] Radiol Med. 2002 Oct;104(4):377-81 [12569322.001]
  • [Cites] Oral Oncol. 2002 Dec;38(8):785-92 [12570058.001]
  • [Cites] Tex Dent J. 2003 Feb;120(2):178, 188-9 [12674967.001]
  • [Cites] Todays FDA. 2002 Dec;14(12):20-1 [12703510.001]
  • [Cites] J Virol Methods. 2003 May;109(2):253-9 [12711070.001]
  • [Cites] J Mass Dent Soc. 2003 Spring;52(1):52-4 [12723214.001]
  • [Cites] Dentomaxillofac Radiol. 2003 May;32(3):141-9 [12917278.001]
  • [Cites] Am J Clin Pathol. 2002 Dec;118 Suppl:S50-70 [14569813.001]
  • [Cites] Cleft Palate Craniofac J. 2003 Nov;40(6):632-8 [14577811.001]
  • [Cites] J Bone Miner Res. 2003 Dec;18(12):2095-104 [14672344.001]
  • [Cites] Int Endod J. 2003 Dec;36(12):907-11 [14689960.001]
  • [Cites] Hum Pathol. 2004 Jan;35(1):69-74 [14745727.001]
  • [Cites] J Oral Pathol Med. 2004 Apr;33(4):246-8 [15061714.001]
  • [Cites] J Oral Maxillofac Surg. 2004 Apr;62(4):519 [15085526.001]
  • [Cites] Ophthalmology. 2000 Aug;107(8):1464-7 [10919890.001]
  • [Cites] Arch Pathol. 1963 May;75:480-95 [13973557.001]
  • [Cites] Ital J Orthop Traumatol. 1976 Aug;2(2):221-37 [1024109.001]
  • [Cites] Acta Radiol Diagn (Stockh). 1977 May;18(3):360-8 [899860.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1978 Feb;45(2):167-74 [272598.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1988 Mar;65(3):339-42 [3162582.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1988 Aug;66(2):249-60 [3140161.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1989 Jun;67(6):698-705 [2740093.001]
  • [Cites] Gaoxiong Yi Xue Ke Xue Za Zhi. 1989 May;5(5):299-303 [2778863.001]
  • [Cites] J Oral Surg (Chic). 1956 Jan;14(1):3-14 [13278814.001]
  • [Cites] Endocrinology. 2004 Dec;145(12):5459-64 [15331575.001]
  • [Cites] Arch Oral Biol. 2005 Feb;50(2):115-22 [15721137.001]
  • [Cites] Pediatr Blood Cancer. 2005 Apr;44(4):390-6 [15602717.001]
  • [Cites] Otol Neurotol. 2005 Mar;26(2):237-40 [15793411.001]
  • [Cites] Bone. 2005 Mar;36(3):542-8 [15777670.001]
  • [Cites] Br Dent J. 2005 Apr 23;198(8):477-8 [15849576.001]
  • [Cites] Clin Genet. 2005 Aug;68(2):190-1 [15996221.001]
  • [Cites] JBR-BTR. 2005 May-Jun;88(3):156-7 [16038240.001]
  • [Cites] Int J Oral Maxillofac Surg. 2005 Jun;34(4):350-6 [16053841.001]
  • [Cites] J Am Dent Assoc. 2005 Jul;136(7):927-31 [16060474.001]
  • [Cites] Clin Sci (Lond). 2005 Sep;109(3):257-63 [16104845.001]
  • [Cites] Clin Orthop Relat Res. 2005 Sep;438:97-102 [16131876.001]
  • [Cites] J Bone Miner Res. 2005 Oct;20(10):1845-50 [16160742.001]
  • [Cites] J Oral Maxillofac Surg. 2005 Oct;63(10):1549-54 [16182928.001]
  • [Cites] J Bone Joint Surg Am. 2005 Nov;87(11):2489-94 [16264125.001]
  • [Cites] Skeletal Radiol. 2005 Dec;34(12):793-8 [16096755.001]
  • [Cites] Bone. 2006 Feb;38(2 Suppl 2):S3-7 [16406763.001]
  • [Cites] J Clin Endocrinol Metab. 2004 May;89(5):2107-13 [15126527.001]
  • [Cites] J Oral Sci. 2004 Mar;46(1):61-4 [15141726.001]
  • [Cites] Int J Oral Maxillofac Surg. 2004 Jul;33(5):498-501 [15183415.001]
  • [Cites] Pediatr Radiol. 2004 Aug;34(8):630-2 [15103427.001]
  • [Cites] Braz Dent J. 2004;15(1):75-8 [15322650.001]
  • [Cites] Semin Nephrol. 2004 Sep;24(5):449-55 [15490409.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1967 Oct;24(4):435-48 [5235465.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1968 Mar;25(3):479-84 [5237482.001]
  • [Cites] J Can Dent Assoc (Tor). 1969 Apr;35(4):208-12 [5251764.001]
  • [Cites] J Oral Surg. 1972 Jul;30(7):517-9 [4503603.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1973 Mar;35(3):340-50 [4510606.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1973 Feb;35(2):190-201 [4513065.001]
  • [Cites] J Oral Pathol. 1972;1(5):189-220 [4199101.001]
  • [Cites] Br J Oral Surg. 1974 Mar;11(3):230-5 [4526020.001]
  • [Cites] Arch Otolaryngol. 1974 Sep;100(3):233-6 [4852156.001]
  • [Cites] Int J Oral Surg. 1974;3(6):440-4 [4217321.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1975 Apr;39(4):590-604 [1054467.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1976 Jan;41(1):62-82 [1061039.001]
  • [Cites] J Pediatr Endocrinol Metab. 2006 May;19 Suppl 2:577-82 [16789620.001]
  • [Cites] J Craniomaxillofac Surg. 1993 Oct;21(7):294-7 [8263214.001]
  • [Cites] Cancer Genet Cytogenet. 1993 Dec;71(2):170-2 [8281522.001]
  • [Cites] Tumori. 1993 Oct 31;79(5):363-6 [8116084.001]
  • [Cites] Br J Oral Maxillofac Surg. 2006 Aug;44(4):322-4 [16310907.001]
  • [Cites] Ann N Y Acad Sci. 2006 Apr;1068:143-64 [16831914.001]
  • [Cites] Am J Pathol. 2006 Aug;169(2):503-14 [16877352.001]
  • [Cites] Calcif Tissue Int. 2006 Jul;79(1):22-6 [16868670.001]
  • [Cites] Nat Clin Pract Rheumatol. 2006 May;2(5):270-7 [16932700.001]
  • [Cites] Am J Otolaryngol. 2006 Sep-Oct;27(5):358-61 [16935186.001]
  • [Cites] J Oral Pathol Med. 1995 Jul;24(6):285-7 [7562667.001]
  • [Cites] Cancer. 1995 Oct 1;76(7):1155-65 [8630892.001]
  • [Cites] Cancer. 1995 Nov 15;76(10):1853-9 [8625058.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Mar;81(3):333-42 [8653468.001]
  • [Cites] Semin Diagn Pathol. 1996 May;13(2):104-12 [8734416.001]
  • [Cites] Int J Oral Maxillofac Surg. 1996 Feb;25(1):54-6 [8833301.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Nov;82(5):577-84 [8936524.001]
  • [Cites] Minerva Stomatol. 1996 Jul-Aug;45(7-8):349-54 [8984329.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Dec;82(6):704-12 [8974145.001]
  • [Cites] Dentomaxillofac Radiol. 1996 Jun;25(3):125-9 [9084260.001]
  • [Cites] J Oral Maxillofac Surg. 1997 Apr;55(4):410-4; 414-5 [9120707.001]
  • [Cites] Curr Opin Rheumatol. 1997 Jul;9(4):347-54 [9229182.001]
  • [Cites] Head Neck. 1997 Sep;19(6):513-23 [9278760.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Sep;84(3):301-9 [9377196.001]
  • [Cites] J Bone Miner Res. 1997 Nov;12(11):1952-3 [9383700.001]
  • [Cites] Proc Staff Meet Mayo Clin. 1963 May 8;38:175-89 [13996066.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1990 Sep;70(3):301-7 [2216357.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1990 Sep;70(3):308-12 [2216358.001]
  • [Cites] Bone Miner. 1990 Nov;11(2):209-16 [2268748.001]
  • [Cites] AJNR Am J Neuroradiol. 1991 Jan-Feb;12(1):25-30 [1899514.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1990 Aug;70(2):241-2 [2290659.001]
  • [Cites] Dentomaxillofac Radiol. 1990 Aug;19(3):137-8 [2088788.001]
  • [Cites] AJR Am J Roentgenol. 1991 Jun;156(6):1199-203 [2028867.001]
  • [Cites] Br J Oral Maxillofac Surg. 1991 Jun;29(3):194-7 [1873290.001]
  • [Cites] J Otolaryngol. 1992 Apr;21(2):112-4 [1583704.001]
  • [Cites] Bone Miner. 1992 Nov;19(2):159-74 [1345324.001]
  • [Cites] Ohio Dent J. 1992 Spring-Summer;66(1):65-8 [1436943.001]
  • [Cites] Acta Otolaryngol Suppl. 1991;488:1-40 [1843064.001]
  • [Cites] Radiol Clin North Am. 1993 Jan;31(1):121-34 [8419969.001]
  • [Cites] Ann Rheum Dis. 1992 Dec;51(12):1335-7 [1485818.001]
  • [Cites] J Oral Maxillofac Surg. 1993 Aug;51(8):828-35 [8336219.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1993 Aug;76(2):200-4 [8361732.001]
  • [Cites] Dentomaxillofac Radiol. 1993 May;22(2):93-6 [8375561.001]
  • [Cites] Cell Mol Life Sci. 2006 Feb;63(4):391-8 [16429324.001]
  • [Cites] J Clin Rheumatol. 2006 Apr;12(2):57-60 [16601537.001]
  • [Cites] J Bone Miner Metab. 2006;24(3):186-90 [16622730.001]
  • [Cites] Joint Bone Spine. 2006 May;73(3):243-8 [16574459.001]
  • [Cites] Calcif Tissue Int. 2006 May;78(5):271-7 [16691492.001]
  • [Cites] J Clin Pathol. 1982 Jul;35(7):771-9 [7096600.001]
  • [Cites] J Bone Miner Res. 1994 Jan;9(1):11-6 [8154304.001]
  • [Cites] Clin Nephrol. 1994 Mar;41(3):173-9 [8187362.001]
  • [Cites] Hum Mol Genet. 1994 Feb;3(2):359-61 [7911698.001]
  • [Cites] Quintessence Int. 2007 Mar;38(3):221-7 [17333999.001]
  • [Cites] Mod Pathol. 2007 Mar;20(3):389-96 [17334331.001]
  • [Cites] Monatsschr Ohrenheilkd Laryngorhinol. 1949 Jan;83(1):1-10 [18116635.001]
  • [Cites] Med Arh. 2000;54(2):115-8 [10934843.001]
  • [Cites] J Bone Miner Res. 2000 Dec;15(12):2330-44 [11127198.001]
  • [Cites] J Mol Diagn. 2000 May;2(2):67-72 [11272890.001]
  • [Cites] Am J Med Genet. 2001 Mar 1;99(2):132-6 [11241472.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Apr;91(4):438-44 [11312460.001]
  • [Cites] Adv Anat Pathol. 2001 May;8(3):126-43 [11345237.001]
  • [Cites] Br J Plast Surg. 2001 Dec;54(8):708-11 [11728115.001]
  • [Cites] J Bone Miner Res. 2002 Jan;17(1):26-9 [11771666.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Mar;93(3):296-304 [11925539.001]
  • [Cites] Oral Dis. 2002 Mar;8(2):106-10 [11991305.001]
  • [Cites] J Dent Assoc S Afr. 1984 Sep;39(9):641 [6596779.001]
  • [Cites] Plast Reconstr Surg. 1999 Mar;103(3):949-54 [10077086.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Nov;84(5):540-9 [9394387.001]
  • [Cites] Aust Dent J. 1997 Dec;42(6):404-8 [9470284.001]
  • [Cites] Eur J Endocrinol. 1998 May;138(5):557-61 [9625369.001]
  • [Cites] J Bone Miner Res. 1998 Jul;13(7):1061-5 [9661069.001]
  • [Cites] Eur Radiol. 1998;8(7):1145-7 [9724428.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Sep;86(3):376-81 [9768431.001]
  • [Cites] Dentomaxillofac Radiol. 1998 Sep;27(5):275-8 [9879216.001]
  • [Cites] J Rheumatol. 1999 Jan;26(1):150-5 [9918257.001]
  • [Cites] Acta Neurol Belg. 1998 Dec;98(4):352-5 [9922824.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Jan;87(1):107-14 [9927089.001]
  • [Cites] Clin Radiol. 1992 May;45(5):316-8 [1516340.001]
  • [Cites] Am J Ophthalmol. 1999 May;127(5):619-21 [10334366.001]
  • [Cites] Am J Hum Genet. 1999 Jul;65(1):158-66 [10364528.001]
  • [Cites] Arch Ital Otol Rinol Laringol. 1953;64(Suppl. 16):1-103 [14350911.001]
  • [Cites] J Oral Surg (Chic). 1957 Apr;15(2):138-42 [13417011.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1958 Jan;11(1):55-68 [13541953.001]
  • [Cites] Hum Pathol. 1999 Dec;30(12):1418-26 [10667418.001]
  • [Cites] J Clin Invest. 2000 Mar;105(5):607-14 [10712432.001]
  • [Cites] J Clin Endocrinol Metab. 2000 Apr;85(4):1449-54 [10770180.001]
  • [Cites] J Oral Surg. 1980 Jan;38(1):65-70 [6927901.001]
  • [Cites] Histopathology. 1980 Jan;4(1):63-74 [7353818.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1980 Feb;49(2):117-21 [6928281.001]
  • [Cites] Br J Oral Surg. 1980 Dec;18(3):221-9 [6934818.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1980 Oct;50(4):372-81 [6935588.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1978 Dec;46(6):765-71 [282541.001]
  • [Cites] Acta Otolaryngol Suppl. 1979;360:61-3 [287355.001]
  • [Cites] J Oral Surg. 1979 Oct;37(10):725-31 [289735.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1982 Jun;53(6):647-50 [6954448.001]
  • [Cites] Skeletal Radiol. 1982;9(2):126-8 [7163823.001]
  • [Cites] Dentomaxillofac Radiol. 1983;12(1):51-6 [6574075.001]
  • [Cites] Am J Ophthalmol. 1983 Nov;96(5):650-3 [6638132.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1984 Feb;57(2):195-9 [6583626.001]
  • [Cites] Ear Nose Throat J. 1984 Aug;63(8):383-92 [6468316.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1984 Oct;58(4):456-60 [6593677.001]
  • [Cites] Ophthalmology. 1985 Jan;92(1):150-9 [3974992.001]
  • [Cites] Cancer. 1968 Oct;22(4):861-78 [5212309.001]
  • [Cites] J Oral Maxillofac Surg. 1985 Apr;43(4):249-62 [3856641.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1985 Mar;59(3):269-74 [3856818.001]
  • [Cites] J Gen Virol. 1985 Oct;66 ( Pt 10):2103-10 [2995550.001]
  • [Cites] Nephron. 1985;41(3):223-9 [4058622.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1985 Nov;60(5):505-11 [3864113.001]
  • [Cites] Ear Nose Throat J. 1985 Oct;64(10):466-72 [4064974.001]
  • [Cites] J Gen Virol. 1986 May;67 ( Pt 5):907-13 [3701300.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1986 Sep;62(3):340-4 [3462639.001]
  • [Cites] Arch Ophthalmol. 1986 Sep;104(9):1347-51 [3753286.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1987;411(6):561-8 [3118565.001]
  • [Cites] J Bone Joint Surg Br. 1988 Mar;70(2):255-60 [3346299.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1994 Sep;78(3):391-6 [7970604.001]
  • [Cites] J Oral Pathol Med. 1994 Oct;23(9):385-8 [7823298.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1994 Nov;78(5):611-20 [7838469.001]
  • [Cites] Yonsei Med J. 1989;30(2):133-43 [2800563.001]
  • [Cites] Clin Orthop Relat Res. 1989 Nov;(248):265-77 [2530018.001]
  • [Cites] Head Neck. 1989 Nov-Dec;11(6):538-44 [2584009.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1989 Dec;68(6):740-7 [2594322.001]
  • [Cites] Br Dent J. 1990 Feb 10;168(3):112-5 [2306394.001]
  • [Cites] J Oral Pathol Med. 1990 Feb;19(2):65-70 [2341974.001]
  • [Cites] J Craniomaxillofac Surg. 1990 Apr;18(3):125-9 [2345185.001]
  • [Cites] J Craniomaxillofac Surg. 1990 May;18(4):169-72 [2193039.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1990 Jul;70(1):81-5 [2371053.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1993 Sep;76(3):351-5 [8378050.001]
  • [Cites] Laryngoscope. 1993 Dec;103(12):1385-90 [8246661.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1993 Nov;76(5):601-7 [8247501.001]
  • (PMID = 20614314.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm
  • [Other-IDs] NLM/ PMC2807558
  • [Keywords] NOTNLM ; Benign fibroosseous lesions / Cementoma / Cementoosseous dysplasia / Fibrous dysplasia / Ossifying fibroma / Osteitis deformans
  •  go-up   go-down


6. Banhiran W, Casiano RR: Endoscopic sinus surgery for benign and malignant nasal and sinus neoplasm. Curr Opin Otolaryngol Head Neck Surg; 2005 Feb;13(1):50-4
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic sinus surgery for benign and malignant nasal and sinus neoplasm.
  • In the recent literature, emphasis has been on the endoscopic surgery of benign tumors, especially inverted papilloma and nasopharyngeal angiofibroma.
  • Other benign neoplasms have also been reported, but only in small case reports.
  • Especially for the more common benign neoplasms, such as inverted papilloma and early stage angiofibroma.

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15654216.001).
  • [ISSN] 1068-9508
  • [Journal-full-title] Current opinion in otolaryngology & head and neck surgery
  • [ISO-abbreviation] Curr Opin Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 43
  •  go-up   go-down


7. Ashraf M, Kumar P, Reza MA, Ragesh KP: Neoplastic diseases of the head & neck in children. Indian J Otolaryngol Head Neck Surg; 2006 Oct;58(4):343-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neoplastic diseases of the head & neck in children.
  • Pediatric neoplasm is next only to trauma as the most common cause of death.
  • The cervicofacial malignancies presents a unique challenge owing to potential adverse effects of both the disease process and the treatment employed on critical developing head and neck structures.This study comprised of 106 children below 12 years age group conducted during 1999-2003 at JNMC, Aligarh.
  • Of 106 cases 70 were benign neoplasms and 36 malignant neoplasms.
  • Nasopharyngeal angiofibroma was the commonest benign tumour and lymphoma was the commonest malignant neoplasm.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Craniomaxillofac Surg. 1988 Aug;16(6):279-86 [3049677.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 1988 Dec;16(3):199-210 [3235286.001]
  • [Cites] Laryngoscope. 1988 Jan;98(1):11-3 [3257285.001]
  • [Cites] JAMA. 1964 Nov 2;190:414-6 [14197990.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2002 Jun;128(6):655-9 [12049559.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2003 Jun;67(6):673-5 [12745163.001]
  • [Cites] Pediatrics. 1963 Aug;32:251-6 [14044453.001]
  • [Cites] Acta Med Okayama. 2000 Aug;54(4):173-7 [10985177.001]
  • (PMID = 23120341.001).
  • [ISSN] 2231-3796
  • [Journal-full-title] Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
  • [ISO-abbreviation] Indian J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3450388
  • [Keywords] NOTNLM ; Lymphoma / Nasopharyngeal angiofibroma / Neoplasm / Rhabdomyosarcoma
  •  go-up   go-down


8. Horiguchi A, Miyakawa S, Ishihara S, Ito M, Asano Y, Furusawa K, Shimizu T, Yamamoto T: Surgical design and outcome of duodenum-preserving pancreatic head resection for benign or low-grade malignant tumors. J Hepatobiliary Pancreat Sci; 2010 Nov;17(6):792-7
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical design and outcome of duodenum-preserving pancreatic head resection for benign or low-grade malignant tumors.
  • To apply duodenum-preserving pancreatic head resection (DPPHR) as radical procedure for benign or low-grade malignant tumors, it needs the reconciliation of complete pancreatic head resection and preservation of the bile duct and peripancreatic vessels.
  • The long-term outcomes of the DPPHR have been reported as extremely rare in comparison with pylorus preserving pancreatoduodenectomy (PPPD) in these pancreatic head tumors.
  • Therefore, we modified the DPPHR to include a complete resection of the pancreatic head and the preservation of both anterior and posterior arterial arcades.
  • We performed 21 DPPHRs and 19 PPPDs in the patients with benign or low-grade malignant pancreatic head tumor.
  • The DPPHR should be favored over the PPPD in benign or low-grade malignant tumors of the head of the pancreas if there is no compromise with oncologic radicality.
  • [MeSH-minor] Angiography. Female. Follow-Up Studies. Humans. Laparotomy. Length of Stay. Male. Middle Aged. Neoplasm Staging. Pancreas / blood supply. Time Factors. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19894017.001).
  • [ISSN] 1868-6982
  • [Journal-full-title] Journal of hepato-biliary-pancreatic sciences
  • [ISO-abbreviation] J Hepatobiliary Pancreat Sci
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


9. Domfeh AB, Fichera M, Hunt JL: Allelic loss of 3 different tumor suppressor gene loci in benign and malignant endothelial tumors of the head and neck. Arch Pathol Lab Med; 2006 Aug;130(8):1184-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Allelic loss of 3 different tumor suppressor gene loci in benign and malignant endothelial tumors of the head and neck.
  • CONTEXT: Angiosarcomas are rare malignancies that commonly arise in the head and neck.
  • OBJECTIVE: This study compared the molecular profile of angiosarcoma with that in some benign vascular lesions.
  • This supports the cell culture-based theories that tumorigenesis in endothelial cells likely involves these chromosomes and provides some insight into the potential pathogenesis of angiosarcomas and benign hemangiomas.
  • [MeSH-major] Genes, Tumor Suppressor. Head and Neck Neoplasms / genetics. Hemangioma / genetics. Hemangiosarcoma / genetics. Loss of Heterozygosity / genetics
  • [MeSH-minor] Chromosomes, Human, Pair 11. Chromosomes, Human, Pair 13. Chromosomes, Human, Pair 17. DNA, Neoplasm / analysis. Endothelium, Vascular / pathology. Genes, Retinoblastoma. Genes, Wilms Tumor. Genes, p53. Genetic Markers. Granulation Tissue / pathology. Humans. Microdissection. Microsatellite Repeats / genetics

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16879020.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / Genetic Markers
  •  go-up   go-down


10. Jang YW, Kim SG, Pai H, Park JW, Lee YC, Rotaru H: Sialolipoma: case report and review of 27 cases. Oral Maxillofac Surg; 2009 Jun;13(2):109-13

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: This article presents a patient with sialolipoma of the submandibular gland, a rare neoplasm, and reviews related literatures.
  • Histopathologically, a tumor was a benign lesion with proliferating lipocytes including scattered foci with a normal salivary gland tissue.
  • CONCLUSION: Sialolipoma is a rare benign neoplasm in the head and neck and it shows equal sex predilection.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Surg Oral Med Oral Pathol. 1973 Oct;36(4):551-7 [4580925.001]
  • [Cites] Ann Diagn Pathol. 2006 Apr;10(2):72-6 [16546040.001]
  • [Cites] J Laryngol Otol. 1993 Mar;107(3):257-8 [8509709.001]
  • [Cites] Br J Oral Maxillofac Surg. 1995 Jun;33(3):196-7 [7654668.001]
  • [Cites] Otolaryngol Head Neck Surg. 2000 Mar;122(3):461-2 [10699830.001]
  • [Cites] Histopathology. 2001 Jan;38(1):30-6 [11135044.001]
  • [Cites] Arch Otolaryngol. 1976 Apr;102(4):230-2 [1267707.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Oct;98(4):441-50 [15472660.001]
  • [Cites] Beitr Pathol Anat. 1959;121:64-80 [14444615.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1966 Jun;21(6):770-7 [5219667.001]
  • [Cites] J Oral Pathol Med. 1994 May;23(5):237-9 [8046661.001]
  • [Cites] Pathol Res Pract. 1999;195(4):247-52 [10337663.001]
  • [Cites] Int J Oral Maxillofac Surg. 2003 Feb;32(1):49-53 [12653233.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Dec;104(6):809-13 [17482843.001]
  • [Cites] Pediatr Dev Pathol. 2007 May-Jun;10 (3):244-6 [17535092.001]
  • [Cites] J Oral Maxillofac Surg. 1991 Nov;49(11):1231-6 [1941342.001]
  • (PMID = 19347375.001).
  • [ISSN] 1865-1550
  • [Journal-full-title] Oral and maxillofacial surgery
  • [ISO-abbreviation] Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 16
  •  go-up   go-down


11. Avninder S, Ramesh V, Vermani S: Benign nerve sheath myxoma (myxoid neurothekeoma) in the leg. Dermatol Online J; 2007;13(2):14
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign nerve sheath myxoma (myxoid neurothekeoma) in the leg.
  • Myxoid neurothekeoma is a rare benign cutaneous neoplasm of nerve sheath origin and is also called as benign nerve sheath myxoma.
  • This entity is seen in head, neck and upper extremity and seldom on the lower limb.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17498433.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Holzmann D, Hegyi I, Rajan GP, Harder-Ruckstuhl M: Management of benign inverted sinonasal papilloma avoiding external approaches. J Laryngol Otol; 2007 Jun;121(6):548-54
Zurich Open Access Repository and Archive. Full text from .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of benign inverted sinonasal papilloma avoiding external approaches.
  • Our results encourage us to recommend endoscopic management as the standard treatment of benign inverted papillomas.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Endoscopy / methods. Humans. Middle Aged. Neoplasm Recurrence, Local. Neoplasm Staging. Prospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17076932.001).
  • [ISSN] 1748-5460
  • [Journal-full-title] The Journal of laryngology and otology
  • [ISO-abbreviation] J Laryngol Otol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


13. Gulcelik NE, Gulcelik MA, Kuru B: Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features. Arch Otolaryngol Head Neck Surg; 2008 Dec;134(12):1312-5
MedlinePlus Health Information. consumer health - Thyroid Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Risk of malignancy in patients with follicular neoplasm: predictive value of clinical and ultrasonographic features.
  • OBJECTIVE: To identify clinical and ultrasonographic features that may help in predicting malignant tumors in patients with a diagnosis of follicular neoplasm on findings from fine-needle aspiration cytology (FNAC) because FNAC diagnosis of follicular neoplasm does not differentiate a benign tumor from a malignant tumor.
  • DESIGN: Prospective study of 98 patients having a diagnosis of follicular neoplasm on FNAC.
  • PATIENTS: Ninety-eight patients with thyroid nodules diagnosed by FNAC as being a follicular neoplasm.
  • Older age, male sex, solitary nodule, and larger nodule size were not predictive for malignant neoplasms in patients with follicular neoplasm cytologic findings.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19075128.001).
  • [ISSN] 1538-361X
  • [Journal-full-title] Archives of otolaryngology--head & neck surgery
  • [ISO-abbreviation] Arch. Otolaryngol. Head Neck Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


14. Lombardi D, Piccioni M, Farina D, Morassi ML, Nicolai P: Oncocytic carcinoma of the maxillary sinus: a rare neoplasm. Eur Arch Otorhinolaryngol; 2006 Jun;263(6):528-31

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oncocytic carcinoma of the maxillary sinus: a rare neoplasm.
  • Most cases are benign and originate from the major salivary glands, while the minor salivary glands are rarely involved.
  • Biopsy was consistent with an unspecified salivary gland neoplasm.
  • A brief analysis of the literature was also accomplished in order to discuss treatment options and prognosis of this unusual neoplasm.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Head Neck Surg. 1988 Jul-Aug;10(6):427-31 [3220785.001]
  • [Cites] South Med J. 1980 Jun;73(6):803-6 [7394618.001]
  • [Cites] J Fr Ophtalmol. 1990;13(3):153-8 [2229900.001]
  • [Cites] Head Neck. 1996 Jul-Aug;18(4):374-80 [8780951.001]
  • [Cites] Otolaryngol Head Neck Surg. 1985 Apr;93(2):267-70 [3921922.001]
  • [Cites] Laryngoscope. 1979 Mar;89(3):372-6 [431244.001]
  • [Cites] Laryngoscope. 1973 Dec;83(12):1940-52 [4772101.001]
  • [Cites] Cancer. 1962 Sep-Oct;15:1019-27 [13904230.001]
  • [Cites] Z Krebsforsch. 1962;64:427-40 [13904235.001]
  • [Cites] J Laryngol Otol. 1979 Jul;93(7):729-34 [469401.001]
  • [Cites] Rev Laryngol Otol Rhinol (Bord). 1989;110(5):481-3 [2633254.001]
  • [Cites] Cancer. 1976 Sep;38(3):1306-17 [953970.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2005 Jul;262(7):567-9 [15592856.001]
  • [Cites] Zentralbl Allg Pathol. 1990;136(7-8):703-6 [2089847.001]
  • [Cites] Arch Otolaryngol. 1968 Jul;88(1):71-3 [5660032.001]
  • (PMID = 16474973.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


15. Shimanovich I, Krahl D, Rose C: Trichoadenoma of Nikolowski is a distinct neoplasm within the spectrum of follicular tumors. J Am Acad Dermatol; 2010 Feb;62(2):277-83
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Trichoadenoma of Nikolowski is a distinct neoplasm within the spectrum of follicular tumors.
  • BACKGROUND: Trichoadenoma is a rare benign follicular tumor first described by Nikolowski 50 years ago.
  • In trichoadenoma the cystic component predominates, while desmoplastic trichoepithelioma is a mostly solid neoplasm.
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / metabolism. Female. Head and Neck Neoplasms / pathology. Humans. Immunohistochemistry. Keratin-20 / metabolism. Male. Merkel Cells / pathology. Middle Aged. Neoplasms, Fibroepithelial / pathology. Receptors, Androgen / metabolism. Skin / chemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
  • (PMID = 20115950.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / AR protein, human; 0 / Biomarkers, Tumor; 0 / Keratin-20; 0 / Receptors, Androgen; 0 / human epithelial antigen-125
  •  go-up   go-down


16. Beger HG, Rau BM, Gansauge F, Schwarz M, Siech M, Poch B: Duodenum-preserving total pancreatic head resection for cystic neoplasm: a limited but cancer-preventive procedure. Langenbecks Arch Surg; 2008 Jul;393(4):589-98
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Duodenum-preserving total pancreatic head resection for cystic neoplasm: a limited but cancer-preventive procedure.
  • A malignant transformation of cystic neoplasia is observed in intraductal papillary mucinous tumor (IPMN) lesions in 60% and in mucinous cystic tumor (MCN) lesions in up to 30%.
  • For cystic neoplasia located monocentrically in the pancreatic head and that do not have an association with an invasive pancreatic cancer, the duodenum-preserving total head resection has been used in recent time as a limited surgical procedure.
  • PATIENTS: An indication to duodenum-preserving total pancreatic head resection is considered for patients who do not have clinical signs of an advanced cancer in the lesion and who have main-duct IPMN and monocentric MCN lesions.
  • The application of a duodenum-preserving total pancreatic head resection in patients with asymptomatic cystic lesion is based on the size of the tumor and the tumor relation to the pancreatic ducts.
  • RESULTS: Duodenum-preserving total pancreatic head resection is used in several modifications.
  • The surgical procedure is a limited pancreatic head resection which necessitates segmental resection of the peripapillary duodenum.
  • The long-term outcome is determined by completeness of resection for both -- benign and malignant -- entities.
  • CONCLUSION: A duodenum-preserving total pancreatic head resection is a limited surgical procedure for patients who suffer a local monocentric, cystic neoplastic lesion in the pancreatic head.
  • Absence of an advanced pancreatic cancer and completeness of extirpation of the benign tumor determine the long-term outcome.
  • In regards to the location of the lesion in the pancreatic head, several modifications have been applied with low hospital morbidity and mortality below 1%.
  • [MeSH-minor] Carcinoma in Situ / pathology. Carcinoma in Situ / surgery. Cell Transformation, Neoplastic / pathology. Common Bile Duct / surgery. Frozen Sections. Humans. Neoplasm Invasiveness. Pancreas / pathology. Prognosis. Suture Techniques. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Pancreatic cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Pediatr Surg. 2006 Dec;41(12):1992-5 [17161189.001]
  • [Cites] Am J Surg. 2001 Feb;181(2):172-6 [11425061.001]
  • [Cites] Am J Surg Pathol. 2004 Aug;28(8):977-87 [15252303.001]
  • [Cites] Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9 [15166958.001]
  • [Cites] Pancreas. 2001 Oct;23(3):309-15 [11590328.001]
  • [Cites] Ann Surg. 2001 Nov;234(5):661-7 [11685030.001]
  • [Cites] Pancreatology. 2006;6(1-2):17-32 [16327281.001]
  • [Cites] Hepatogastroenterology. 1998 Mar-Apr;45(20):533-5 [9638444.001]
  • [Cites] Am J Surg Pathol. 1998 Feb;22(2):163-9 [9500216.001]
  • [Cites] Am J Surg. 2000 Jun;179(6):482-4 [11004335.001]
  • [Cites] Gut. 2007 Aug;56(8):1086-90 [17127707.001]
  • [Cites] Arch Surg. 2003 Feb;138(2):162-8; discussion 168 [12578411.001]
  • [Cites] Arch Surg. 1999 Oct;134(10 ):1131-6 [10522860.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2003;10(2):156-62 [14505149.001]
  • [Cites] Ann Surg. 1997 Oct;226(4):491-8; discussion 498-500 [9351717.001]
  • [Cites] Am J Surg Pathol. 2006 Dec;30(12):1561-9 [17122512.001]
  • [Cites] Oncol Rep. 2003 Jan-Feb;10(1):21-5 [12469138.001]
  • [Cites] Pancreas. 2004 Apr;28(3):241-6 [15084964.001]
  • [Cites] Ann Surg. 2007 Dec;246(6):923-8; discussion 929-31 [18043093.001]
  • [Cites] J Gastrointest Surg. 2003 Jan;7(1):12-8; discussion 18-9 [12559180.001]
  • [Cites] Dig Surg. 2004;21(3):242-5 [15237258.001]
  • [Cites] Arch Surg. 2002 Nov;137(11):1274-8 [12413317.001]
  • [Cites] Hepatogastroenterology. 2001 May-Jun;48(39):879-83 [11462947.001]
  • [Cites] Am J Surg. 1997 Mar;173(3):210-2 [9124628.001]
  • [Cites] J Gastrointest Surg. 2004 Sep-Oct;8(6):713-9 [15358333.001]
  • [Cites] Surgery. 2002 Jul;132(1):80-5 [12110799.001]
  • [Cites] J Clin Gastroenterol. 2003 Mar;36(3):261-5 [12590239.001]
  • [Cites] Clin Gastroenterol Hepatol. 2004 Nov;2(11):1026-31 [15551256.001]
  • [Cites] Surgery. 2003 Jul;134(1):53-62 [12874583.001]
  • [Cites] J Gastroenterol Hepatol. 2005 Sep;20(9):1379-84 [16105124.001]
  • [Cites] Am J Surg. 1995 Jan;169(1):65-9; discussion 69-70 [7818000.001]
  • [Cites] Int J Gastrointest Cancer. 2002;31(1-3):117-21 [12622422.001]
  • [Cites] Am J Surg Pathol. 2000 Oct;24(10):1372-7 [11023098.001]
  • [Cites] Ann Surg. 2001 Sep;234(3):313-21; discussion 321-2 [11524584.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2002;9(1):76-85 [12021900.001]
  • [Cites] Arch Surg. 2003 Jun;138(6):610-7; discussion 617-8 [12799331.001]
  • [Cites] Ann Surg. 2004 May;239(5):678-85; discussion 685-7 [15082972.001]
  • [Cites] Cancer. 2002 Jan 1;94(1):62-77 [11815961.001]
  • [Cites] Surgery. 2002 May;131(5):577-80 [12019413.001]
  • [Cites] Hepatogastroenterology. 1993 Aug;40(4):356-9 [8406305.001]
  • [Cites] Br J Surg. 2001 Mar;88(3):376-81 [11260102.001]
  • [Cites] Eur J Surg. 2000 Feb;166(2):141-8 [10724492.001]
  • [Cites] Ann Surg. 2004 Mar;239(3):400-8 [15075659.001]
  • [Cites] Gut. 2002 Jun;50(6):861-8 [12010891.001]
  • [Cites] J Hepatobiliary Pancreat Surg. 2008;15(2):149-56 [18392707.001]
  • [Cites] Am J Gastroenterol. 1999 Feb;94(2):470-3 [10022648.001]
  • [Cites] Ann Surg. 2007 Oct;246(4):644-51; discussion 651-4 [17893501.001]
  • [Cites] Mod Pathol. 2002 Oct;15(10):1087-95 [12379756.001]
  • [Cites] Chirurg. 1995 Apr;66(4):350-9 [7634946.001]
  • (PMID = 18379818.001).
  • [ISSN] 1435-2451
  • [Journal-full-title] Langenbeck's archives of surgery
  • [ISO-abbreviation] Langenbecks Arch Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


17. Ichimura T, Kondo S, Okamura K, Tanaka E, Hirano S: Total parenchymal pancreatectomy preserving the duodenum, choledochus and spleen for widespread intraductal papillary mucinous neoplasm: report of a case. Hepatogastroenterology; 2010 Jan-Feb;57(97):8-11
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Total parenchymal pancreatectomy preserving the duodenum, choledochus and spleen for widespread intraductal papillary mucinous neoplasm: report of a case.
  • For patients with benign or low malignant diseases of the pancreas, several organ-preserving surgical techniques of pancreatectomy have been presented for localized lesions.
  • We herein report a patient with widespread intraductal papillary mucinous neoplasm treated successfully with total parenchymal pancreatectomy.
  • A 73-year-old man was diagnosed as main duct intraductal papillary mucinous neoplasm.
  • A papillary tumor was located in the body of the pancreas, and intraepithelial spreading reached almost the end of the pancreas tail and nearly over the midpoint of the pancreas head.

  • Genetic Alliance. consumer health - Spleen neoplasm.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20422863.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


18. Chetty R, Serra S: Intraductal tubular adenoma (pyloric gland-type) of the pancreas: a reappraisal and possible relationship with gastric-type intraductal papillary mucinous neoplasm. Histopathology; 2009 Sep;55(3):270-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraductal tubular adenoma (pyloric gland-type) of the pancreas: a reappraisal and possible relationship with gastric-type intraductal papillary mucinous neoplasm.
  • AIMS: Intraductal tubular adenoma (ITA) is an uncommon intraluminal polypoid lesion that occurs in the main pancreatic duct and involves the main pancreatic duct in the region of head or body.
  • Three cases of ITA are presented, the literature reviewed and their association with intraductal papillary mucinous neoplasm (IPMN) is postulated.
  • Pancreatic intraepithelial neoplasia (PanIN) 1A and B was present in smaller ducts of all cases.
  • ITA could represent a localized, polypoid form of gastric-type IPMN.It is a benign lesion with no evidence of invasion and no direct tumour-related deaths.

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Histopathology. 2010 Jun;56(7):968-9; author reply 969 [20636797.001]
  • (PMID = 19723141.001).
  • [ISSN] 1365-2559
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


19. Baradaranfar MH, Dabirmoghaddam P: Endoscopic endonasal surgery for resection of benign sinonasal tumors: experience with 105 patients. Arch Iran Med; 2006 Jul;9(3):244-9
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic endonasal surgery for resection of benign sinonasal tumors: experience with 105 patients.
  • OBJECTIVE: To report our experience with endoscopic surgery of benign tumors and tumor-like conditions of the nose and paranasal sinuses.
  • METHODS: The medical records of 105 patients with benign sinonasal tumor, who had undergone endoscopic surgery for removal of their neoplasm between 1997 and 2003, were retrospectively studied.
  • RESULTS: The studied patients included 32 with juvenile nasopharyngeal angiofibroma, 24 with inverted papilloma, 23 with benign fibroosseous lesions, 18 with pyogenic granuloma, 6 with intranasal hemangioma, and 2 with pleomorphic adenoma.
  • CONCLUSION: Endoscopic surgery is a valuable tool for removal of benign tumors of the nose and paranasal sinuses in the hands of an experienced surgeon.

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16859060.001).
  • [ISSN] 1029-2977
  • [Journal-full-title] Archives of Iranian medicine
  • [ISO-abbreviation] Arch Iran Med
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Iran
  •  go-up   go-down


20. Zhang H, Feng Y, Jiang L: [Tumorectomy by trans-oral approach of macrosis benign neoplasms in parapharyngeal space (reports of 6 cases)]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jun;24(12):556-8
MedlinePlus Health Information. consumer health - Throat Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Tumorectomy by trans-oral approach of macrosis benign neoplasms in parapharyngeal space (reports of 6 cases)].
  • OBJECTIVE: To discuss the feasibility of tumorectomy by transoral approach of macrosis benign neoplasms in parapharyngeal space.
  • METHOD: Retrospective analyze 6 patients of macrosis benign neoplasms in parapharyngeal space from January 2005 to May 2008, and all neoplasms were removed by transoral approach.
  • CONCLUSION: Preoperative imaging examination is very important for diagnosis and treatment of benign neoplasm in parapharyngeal space, which is especially helpful to understand the scope of the tumor, and the relationship with carotid artery and vein.
  • On this basis, it is feasible to select the appropriate cases to resect huge benign neoplasm in parapharyngeal space.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20806862.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


21. Nakao A, Takeda S, Nomoto S, Kanazumi N, Kasuya H, Sugimoto H, Fujii T, Yamada S: Pancreatic head resection with segmental duodenectomy for pancreatic neoplasms. J Hepatobiliary Pancreat Sci; 2010 Nov;17(6):788-91
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreatic head resection with segmental duodenectomy for pancreatic neoplasms.
  • BACKGROUND/PURPOSE: We have experienced 67 cases of pancreatic head resection with segmental duodenectomy (PHRSD) for benign or low-grade malignant tumor of the pancreatic head region.
  • METHODS: Pancreatic head resection is performed with segmental duodenectomy including minor and major papilla.
  • The procedure is completed by resection of the pancreatic head with 3-4 cm of segmental duodenectomy including minor and major papilla.
  • RESULTS: In 67 cases with diseases of the pancreatic head region, chiefly intraductal papillary mucinous neoplasms, this procedure was successfully performed without operative or hospital death.
  • CONCLUSION: Total resection of the pancreatic head can be performed safely and effectively by this procedure.
  • [MeSH-minor] Adenocarcinoma, Mucinous / diagnosis. Adenocarcinoma, Mucinous / surgery. Carcinoma, Pancreatic Ductal / diagnosis. Carcinoma, Pancreatic Ductal / surgery. Choledochostomy / methods. Follow-Up Studies. Humans. Neoplasm Staging. Quality of Life. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19882374.001).
  • [ISSN] 1868-6982
  • [Journal-full-title] Journal of hepato-biliary-pancreatic sciences
  • [ISO-abbreviation] J Hepatobiliary Pancreat Sci
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


22. Wang CP, Chang YL, Ko JY, Cheng CH, Yeh CF, Lou PJ: Desmoid tumor of the head and neck. Head Neck; 2006 Nov;28(11):1008-13
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumor of the head and neck.
  • BACKGROUND: [corrected] Desmoid tumors are rare benign tumors but have a tendency toward local recurrence after resection because of their infiltrative growth and frequent entrapment of vital structures in the head and neck region.
  • We report 24 desmoid tumors of the head and neck and propose a reasonable approach in the management of such cases.
  • METHODS: Twenty-four patients (9 male and 15 female; median age, 33 years; range, 0-66 years) with a desmoid tumor of the head and neck (neck, 15 patients; head, 9 patients) treated from 1990 to 2004 were retrospectively analyzed.
  • [MeSH-major] Fibromatosis, Aggressive / surgery. Head and Neck Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Female. Humans. Infant. Infant, Newborn. Male. Middle Aged. Neoplasm Recurrence, Local / surgery. Radiotherapy, Adjuvant. Retrospective Studies

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16983695.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


23. Henrique R, Jerónimo C, Hoque MO, Carvalho AL, Oliveira J, Teixeira MR, Lopes C, Sidransky D: Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions. DNA Cell Biol; 2005 Apr;24(4):264-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
  • Here, we investigate the frequency and extent of 14-3-3sigma promoter methylation in benign and cancerous prostate tissues.
  • We examined tumor tissue from 121 patients with prostate carcinoma (PCa), 39 paired high-grade prostatic intraepithelial neoplasias (HGPIN), 29 patients with benign prostate hyperplasia (BPH), as well as four prostate cancer cell lines using quantitative methylation-specific PCR (QMSP).
  • [MeSH-major] Adenocarcinoma / genetics. Biomarkers, Tumor / metabolism. DNA Methylation. Exonucleases / metabolism. Gene Silencing. Neoplasm Proteins / metabolism. Prostatic Hyperplasia / genetics. Prostatic Intraepithelial Neoplasia / genetics. Prostatic Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Enlarged Prostate (BPH).
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15812243.001).
  • [ISSN] 1044-5498
  • [Journal-full-title] DNA and cell biology
  • [ISO-abbreviation] DNA Cell Biol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 14-3-3 Proteins; 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins; EC 3.1.- / Exonucleases; EC 3.1.- / Exoribonucleases; EC 3.1.- / SFN protein, human
  •  go-up   go-down


24. Sanabria A, Carvalho AL, Piana de Andrade V, Pablo Rodrigo J, Vartanian JG, Rinaldo A, Ikeda MK, Devaney KO, Magrin J, Augusto Soares F, Ferlito A, Kowalski LP: Is galectin-3 a good method for the detection of malignancy in patients with thyroid nodules and a cytologic diagnosis of "follicular neoplasm"? A critical appraisal of the evidence. Head Neck; 2007 Nov;29(11):1046-54
PubMed Health. DARE review .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is galectin-3 a good method for the detection of malignancy in patients with thyroid nodules and a cytologic diagnosis of "follicular neoplasm"? A critical appraisal of the evidence.
  • Immunostaining of cytological smears from FNAB with galectin-3 has been proposed as a tool for differentiating between benign and malignant nodules.
  • METHODS: Prospective studies of nodules with FNAB reports of "follicular neoplasm" and with a definitive diagnosis confirmed by histopathology were selected.
  • CONCLUSION: Galectin-3 could be a good tool to guide therapeutic decision in patients with thyroid nodules and FNAB results of follicular neoplasm, but available information has methodological flaws that precludes a definitive answer about galectin-3 utility in the clinical setting.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17525969.001).
  • [ISSN] 1043-3074
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Galectin 3
  • [Number-of-references] 68
  •  go-up   go-down


25. Sakamoto K, Ono T, Nakamura Y, Harada H, Nakashima T: Expression of cluster of differentiation 9 glycoprotein in benign and malignant parotid gland tumours. J Laryngol Otol Suppl; 2009;(31):58-63

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of cluster of differentiation 9 glycoprotein in benign and malignant parotid gland tumours.
  • Regarding benign parotid gland tumours, cluster of differentiation 9 glycoprotein was present in 13 of 18 pleomorphic adenomas, in all Warthin tumours tested (21/21) and in all cases of basal cell adenoma tested (four of four).
  • CONCLUSIONS: There was a statistically significantly reduced expression of cluster of differentiation 9 glycoprotein in malignant parotid gland tumours, compared with benign parotid gland tumours (p < 0.05).
  • [MeSH-major] Antigens, CD / analysis. Membrane Glycoproteins / analysis. Neoplasm Proteins / analysis. Parotid Gland / chemistry. Parotid Neoplasms / chemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19460206.001).
  • [ISSN] 0144-2945
  • [Journal-full-title] The Journal of laryngology and otology. Supplement
  • [ISO-abbreviation] J Laryngol Otol Suppl
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD9; 0 / CD9 protein, human; 0 / Membrane Glycoproteins; 0 / Neoplasm Proteins
  •  go-up   go-down


26. Bolzoni A, Pianta L, Farina D, Nicolai P: Benign myoepithelioma of the lacrimal gland: report of a case. Eur Arch Otorhinolaryngol; 2005 Mar;262(3):186-8
MedlinePlus Health Information. consumer health - Eye Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign myoepithelioma of the lacrimal gland: report of a case.
  • A mass in the right lacrimal fossa was detected at MRI and turned out to be benign myoepithelioma of the lacrimal gland at the histopathological examination.
  • [MeSH-minor] Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Staging. Surgical Procedures, Operative / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Ophthalmol. 1992 Oct;76(10):634-6 [1329939.001]
  • [Cites] Arch Ophthalmol. 1997 Dec;115(12):1588-90 [9400797.001]
  • [Cites] Radiol Clin North Am. 1999 Jan;37(1):219-39, xii [10026740.001]
  • [Cites] Nippon Ganka Gakkai Zasshi. 2001 Jan;105(1):42-6 [11210787.001]
  • [Cites] Arch Ophthalmol. 1990 Aug;108(8):1135-9 [2166496.001]
  • [Cites] Ultrastruct Pathol. 1989 Mar-Jun;13(2-3):187-224 [2544051.001]
  • [Cites] Pathol Int. 2000 Mar;50(3):238-43 [10792788.001]
  • [Cites] Otolaryngol Clin North Am. 2001 Dec;34(6):1157-74, ix-x [11728939.001]
  • [Cites] Pathobiology. 1990;58(6):312-22 [1706602.001]
  • (PMID = 15138773.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 9
  •  go-up   go-down


27. Vanbeckevoort D: Solid pancreatic masses: benign or malignant. JBR-BTR; 2007 Nov-Dec;90(6):487-9
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solid pancreatic masses: benign or malignant.
  • Solid masses in the pancreas mostly occur in the pancreatic head and may be related to inflammation due to chronic pancreatitis or may be caused by malignancy.
  • Ductal pancreatic carcinoma is the most common malignant pancreatic neoplasm, accounting for more than 90% of malignant solid pancreatic tumours.

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18376761.001).
  • [ISSN] 0302-7430
  • [Journal-full-title] JBR-BTR : organe de la Société royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)
  • [ISO-abbreviation] JBR-BTR
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Belgium
  • [Number-of-references] 13
  •  go-up   go-down


28. Miura T, Igarashi Y, Okano N, Miki K, Okubo Y: Endoscopic diagnosis of intraductal papillary-mucinous neoplasm of the pancreas by means of peroral pancreatoscopy using a small-diameter videoscope and narrow-band imaging. Dig Endosc; 2010 Apr;22(2):119-23
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic diagnosis of intraductal papillary-mucinous neoplasm of the pancreas by means of peroral pancreatoscopy using a small-diameter videoscope and narrow-band imaging.
  • BACKGROUND: Intraductal papillary-mucinous neoplasm (IPMN) is an intraductal tumor in which the mucin-producing epithelium shows proliferated papillary and a wide variety of pathological changes ranging from hyperplasia to adenocarcinoma.
  • Therefore, it is important to determine whether an IPMN is benign or malignant.
  • We carried out the differential diagnosis of benign lesion to malignant lesion.
  • RESULTS: Fifteen focal lesions of the 16 cases in the head of the pancreas (93.7%) and four focal lesions of the five cases in the pancreatic body (80%) were observable, whereas two lesions (adenocarcinoma in the pancreatic body, and adenoma in the uncus of pancreas) were not observable.
  • CONCLUSIONS: When combined with a videoscope and NBI, pancreatoscopy provided a clear image and was useful for evaluating whether the IPMN was benign or malignant.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20447205.001).
  • [ISSN] 1443-1661
  • [Journal-full-title] Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
  • [ISO-abbreviation] Dig Endosc
  • [Language] eng
  • [Publication-type] Controlled Clinical Trial; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


29. Laskin WB, Fetsch JF, Lasota J, Miettinen M: Benign epithelioid peripheral nerve sheath tumors of the soft tissues: clinicopathologic spectrum of 33 cases. Am J Surg Pathol; 2005 Jan;29(1):39-51
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign epithelioid peripheral nerve sheath tumors of the soft tissues: clinicopathologic spectrum of 33 cases.
  • Benign epithelioid peripheral nerve sheath tumors (BEPNSTs) have not been fully characterized, and their relationship to conventional schwannoma and neurofibroma has not been satisfactorily established.
  • The tumors were predominantly dermal/subcutaneous in location (85%) and involved the lower limb (n=15), upper limb (n=11), trunk (n=4), and head/neck (n=3).
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / metabolism. Child. Child, Preschool. DNA, Neoplasm / analysis. Female. Humans. Immunoenzyme Techniques. Loss of Heterozygosity. Male. Middle Aged. Mitotic Index. Neurofibromin 1 / genetics. Neurofibromin 1 / metabolism. Neurofibromin 2 / genetics. Neurofibromin 2 / metabolism. Polymerase Chain Reaction

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15613855.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / DNA, Neoplasm; 0 / Neurofibromin 1; 0 / Neurofibromin 2
  •  go-up   go-down


30. Fei Z, Zhang X, Jiang XF, Liu WP, Wang XL, Xie L: Removal of large benign cephalonasal tumours by transbasal surgery combined with endonasal endoscopic sinus surgery and neuronavigation. J Craniomaxillofac Surg; 2007 Jan;35(1):30-4
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Removal of large benign cephalonasal tumours by transbasal surgery combined with endonasal endoscopic sinus surgery and neuronavigation.
  • CONCLUSION: Transbasal surgery combined with endonasal endoscopic sinus surgery and neuronavigation is a particularly useful technique for resecting large benign cephalonasal tumours.
  • [MeSH-major] Endoscopy / methods. Head and Neck Neoplasms / surgery. Neuronavigation / methods. Skull Base / surgery
  • [MeSH-minor] Abducens Nerve Diseases / etiology. Adolescent. Adult. Child. Child, Preschool. Deglutition Disorders / etiology. Female. Follow-Up Studies. Humans. Male. Middle Aged. Nasal Cavity / surgery. Neoplasm Recurrence, Local / surgery. Neoplasm, Residual / pathology. Nose Neoplasms / surgery. Olfaction Disorders / etiology. Ophthalmoplegia / etiology. Paralysis / etiology. Paranasal Sinus Neoplasms / surgery. Radiotherapy, Adjuvant. Reoperation. Retrospective Studies. Skull Base Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17261369.001).
  • [ISSN] 1010-5182
  • [Journal-full-title] Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
  • [ISO-abbreviation] J Craniomaxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Scotland
  •  go-up   go-down


31. Fukunaga N, Ishikawa M, Minato T, Yamamura Y, Ishikura H, Ichimori T, Kimura S, Sakata A, Fujii Y: Lymphoepithelial cyst of the pancreas that was difficult to distinguish from branch duct-type intraductal papillary mucinous neoplasm: report of a case. Surg Today; 2009;39(10):901-4
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymphoepithelial cyst of the pancreas that was difficult to distinguish from branch duct-type intraductal papillary mucinous neoplasm: report of a case.
  • A computed tomography (CT) scan showed a 30-mmdiameter, multilocular cyst in the head of the pancreas.
  • Based on these findings, we suspected a branch duct type intraductal papillary mucinous neoplasm.
  • Pathologically, the cyst wall was lined with squamous epithelium surrounded by abundant lymphoid tissue with follicles, consistent with a lymphoepithelial cyst of the pancreas, which is an unusual benign cyst.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Comput Assist Tomogr. 1995 Mar-Apr;19(2):221-4 [7890845.001]
  • [Cites] Pathologe. 1985 Jul;6(4):217-9 [4048076.001]
  • [Cites] Am J Surg. 1995 Jul;170(1):27-32 [7793490.001]
  • [Cites] J Gastrointest Surg. 2004 Mar-Apr;8(3):342-5 [15019932.001]
  • [Cites] Semin Diagn Pathol. 2000 Feb;17(1):56-65 [10721807.001]
  • [Cites] Abdom Imaging. 1998 Mar-Apr;23 (2):185-7 [9516512.001]
  • [Cites] Am J Surg Pathol. 1987 Nov;11(11):899-903 [3674287.001]
  • [Cites] Surg Today. 2008;38(1):68-71 [18085369.001]
  • [Cites] JOP. 2008 Jan 08;9(1):46-9 [18182743.001]
  • [Cites] JOP. 2008 Mar 08;9(2):230-4 [18326936.001]
  • [Cites] Cancer. 2006 Dec 25;108(6):501-6 [17063496.001]
  • (PMID = 19784732.001).
  • [ISSN] 1436-2813
  • [Journal-full-title] Surgery today
  • [ISO-abbreviation] Surg. Today
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


32. Mendes RA, Carvalho JF, Waal Iv: An overview on the expression of cyclooxygenase-2 in tumors of the head and neck. Oral Oncol; 2009 Oct;45(10):e124-8
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An overview on the expression of cyclooxygenase-2 in tumors of the head and neck.
  • Cyclooxygenase-2 (COX-2) levels are increased in various tumors, particularly those involving the esophagus, stomach, breast, pancreas, lung, colon, skin, urinary bladder, prostate and head and neck.
  • Furthermore, the expression of COX-2 might shed some light over the physiopathology and clinical behavior of tumors of the head and neck, including benign odontogenic neoplasms of the jaws with an aggressive behavior, such as keratocystic odontogenic tumors (KCOT).
  • [MeSH-major] Cyclooxygenase 2 / metabolism. Head and Neck Neoplasms / metabolism. Neoplasm Proteins / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19457709.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Neoplasm Proteins; 0 / Prostaglandins; EC 1.14.99.1 / Cyclooxygenase 2
  •  go-up   go-down


33. Pinchot SN, Al-Wagih H, Schaefer S, Sippel R, Chen H: Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or larger. Arch Surg; 2009 Jul;144(7):649-55
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or larger.
  • The FNAB results were reported as nondiagnostic, benign, inconclusive (follicular neoplasm), or malignant, whereas the final surgical pathologic data were reported as benign or malignant.
  • Preoperative cytologic testing of the mass was performed on 97 patients, and the results read as benign for 52, inconclusive for 23, nondiagnostic for 11, and malignant for 11.
  • In lesions 4 cm or larger, 26 of 52 FNAB results reported as benign (50.0%) turned out to be either neoplastic (22) or malignant (4) on final pathologic analysis.
  • CONCLUSIONS: In patients with thyroid nodules 4 cm or larger, the FNAB results are highly inaccurate, misclassifying half of all patients with reportedly benign lesions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Control. 2006 Apr;13(2):89-98 [16735982.001]
  • [Cites] Ann Surg Oncol. 2006 Jun;13(6):859-63 [16614881.001]
  • [Cites] Clin Endocrinol (Oxf). 2006 Oct;65(4):500-5 [16984243.001]
  • [Cites] Ann Surg. 2007 Nov;246(5):714-20 [17968160.001]
  • [Cites] Surgery. 2007 Dec;142(6):837-44; discussion 844.e1-3 [18063065.001]
  • [Cites] J Clin Endocrinol Metab. 2008 Mar;93(3):809-14 [18160464.001]
  • [Cites] Surgery. 2008 Jun;143(6):835-6 [18549905.001]
  • [Cites] Otolaryngol Head Neck Surg. 2008 Jul;139(1):27-31 [18585557.001]
  • [Cites] Ann Surg. 2008 Aug;248(2):343-4; author reply 344 [18650649.001]
  • [Cites] Otolaryngol Head Neck Surg. 2000 Jun;122(6):917-21 [10828810.001]
  • [Cites] N Engl J Med. 2004 Oct 21;351(17):1764-71 [15496625.001]
  • [Cites] Surgery. 1988 Dec;104(6):947-53 [3194846.001]
  • [Cites] Acta Endocrinol (Copenh). 1989 Aug;121(2):197-202 [2773619.001]
  • [Cites] Radiology. 1991 Dec;181(3):683-7 [1947082.001]
  • [Cites] J Surg Oncol. 1992 Aug;50(4):247-50 [1640709.001]
  • [Cites] Ann Intern Med. 1993 Feb 15;118(4):282-9 [8420446.001]
  • [Cites] Cancer. 1993 Nov 1;72(9):2680-5 [8402490.001]
  • [Cites] Surgery. 1993 Dec;114(6):1050-7; discussion 1057-8 [8256208.001]
  • [Cites] Arch Intern Med. 1994 Aug 22;154(16):1838-40 [8053752.001]
  • [Cites] Surgery. 1995 Dec;118(6):996-1003; discussion 1003-4 [7491545.001]
  • [Cites] Mayo Clin Proc. 1997 Oct;72(10):913-6 [9379692.001]
  • [Cites] J Clin Endocrinol Metab. 1955 Oct;15(10):1270-80 [13263417.001]
  • [Cites] Thyroid. 2005 Jul;15(7):708-17 [16053388.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Sep;91(9):3411-7 [16835280.001]
  • (PMID = 19620545.001).
  • [ISSN] 1538-3644
  • [Journal-full-title] Archives of surgery (Chicago, Ill. : 1960)
  • [ISO-abbreviation] Arch Surg
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA090217-08; United States / NCI NIH HHS / CA / T32 CA090217-09; United States / NCI NIH HHS / CA / T32 CA090217-10; United States / NCI NIH HHS / CA / T32 CA090217; United States / NCI NIH HHS / CA / CA090217-10; United States / NCI NIH HHS / CA / T32 CA090217-08; United States / NCI NIH HHS / CA / CA090217-09
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS215984; NLM/ PMC2910711
  •  go-up   go-down


34. Ungari C, Paparo F, Colangeli W, Iannetti G: Parotid glands tumours: overview of a 10-year experience with 282 patients, focusing on 231 benign epithelial neoplasms. Eur Rev Med Pharmacol Sci; 2008 Sep-Oct;12(5):321-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Parotid glands tumours: overview of a 10-year experience with 282 patients, focusing on 231 benign epithelial neoplasms.
  • Salivary gland tumours are uncommon, representing less than 6% of head and neck neoplasm.
  • Pleomorphic adenoma is the most common benign epithelial salivary gland neoplasm, comprising 50%-74% of all parotid tumours.
  • The authors retrospectively reviewed 282 eligible patients surgically treated for parotid gland tumours in the last 10 years, focusing on 231 benign epithelial neoplasms.
  • The diagnosis of a parotid gland neoplasm must be considered in any patient presenting with a lump near the mandible.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19024217.001).
  • [ISSN] 1128-3602
  • [Journal-full-title] European review for medical and pharmacological sciences
  • [ISO-abbreviation] Eur Rev Med Pharmacol Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


35. Juhlin J, Eiholm S: [Rhabdomyoma in the head and neck region]. Ugeskr Laeger; 2009 Mar 30;171(14):1194
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Rhabdomyoma in the head and neck region].
  • Extracardiac rhabdomyoma is an extremely uncommon benign neoplasm with skeletal muscle differentiation which usually involves the head and neck region.
  • Adult rhabdomyomas should be considered as a differential diagnosis in the head and neck region.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Rhabdomyoma / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19338741.001).
  • [ISSN] 1603-6824
  • [Journal-full-title] Ugeskrift for laeger
  • [ISO-abbreviation] Ugeskr. Laeg.
  • [Language] dan
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


36. Valdez TA, Desai U, Volk MS: Recurrent fetal rhabdomyoma of the head and neck. Int J Pediatr Otorhinolaryngol; 2006 Jun;70(6):1115-8
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent fetal rhabdomyoma of the head and neck.
  • A congenital fetal rhabdomyoma involving the head and neck region diagnosed prenatally by ultrasound and MRI was surgically excised without complications.
  • Extracardiac rhabdomyomas are extremely rare benign tumors.
  • [MeSH-major] Head and Neck Neoplasms / congenital. Neoplasm Recurrence, Local / pathology. Rhabdomyoma / congenital

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16406074.001).
  • [ISSN] 0165-5876
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Ireland
  • [Number-of-references] 11
  •  go-up   go-down


37. Papaspyrou K, Mann WJ, Amedee RG: Management of head and neck paragangliomas: review of 120 patients. Head Neck; 2009 Mar;31(3):381-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of head and neck paragangliomas: review of 120 patients.
  • BACKGROUND: Head and neck paragangliomas (PGL) are rare, mostly benign tumors.
  • METHODS AND RESULTS: A retrospective review of 120 patients with 146 head and neck PGL, including 46 carotid body tumors (CBT), 13 vagal tumors, 55 jugulotympanic tumors (JTT), 25 tympanic tumors (TT) and 7 tumors in other locations are included.
  • [MeSH-major] Head and Neck Neoplasms / therapy. Outcome Assessment (Health Care). Paraganglioma / therapy
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Carotid Artery, Internal. Child. Cranial Nerve Diseases / etiology. Deafness / etiology. Deafness / prevention & control. Embolization, Therapeutic. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Postoperative Complications. Radiotherapy, Adjuvant. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18972432.001).
  • [ISSN] 1097-0347
  • [Journal-full-title] Head & neck
  • [ISO-abbreviation] Head Neck
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Subbiah S, Collins BJ, Schneider AB: Factors related to the recurrence of thyroid nodules after surgery for benign radiation-related nodules. Thyroid; 2007 Jan;17(1):41-7
Hazardous Substances Data Bank. LEVOTHYROXINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Factors related to the recurrence of thyroid nodules after surgery for benign radiation-related nodules.
  • OBJECTIVE: Benign thyroid nodules are increased by radiation exposure and recurrences are common.
  • DESIGN, SETTING, AND SUBJECTS: The study population was drawn from a cohort of 4296 people treated before the age of 16 with conventional external radiation for benign conditions of the head and neck between 1939 and the early 1960s.
  • The study group consisted of 632 subjects who had benign nodules removed surgically.
  • [MeSH-major] Neoplasm Recurrence, Local / epidemiology. Thyroid Neoplasms. Thyroid Nodule

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17274748.001).
  • [ISSN] 1050-7256
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA 21518
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 9002-71-5 / Thyrotropin; Q51BO43MG4 / Thyroxine
  •  go-up   go-down


39. Gleason BC, Fletcher CD: Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential. Am J Surg Pathol; 2008 Mar;32(3):354-62
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deep "benign" fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential.
  • Benign fibrous histiocytoma (FH) is one of the most common mesenchymal neoplasms of the skin.
  • Deep benign FH is an uncommon and poorly recognized clinical subtype that arises in subcutaneous or deep soft tissue.
  • The most common anatomic location was the extremities (58%); the remainder arose on the head and neck (22%), trunk (11%), and in the deep soft tissue of the retroperitoneum, mediastinum, or pelvis (9%).
  • [MeSH-major] Histiocytoma, Benign Fibrous / pathology. Neoplasm Metastasis / pathology. Skin Neoplasms / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Actins / analysis. Adolescent. Adult. Aged. Aged, 80 and over. Antigens, CD34 / analysis. Child. Desmin / analysis. Female. Humans. Immunohistochemistry. Male. Middle Aged. Mitosis. Necrosis. Neoplasm Recurrence, Local

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18300816.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Antigens, CD34; 0 / Desmin
  •  go-up   go-down


40. Ozawa H, Tomita T, Sakamoto K, Tagawa T, Fujii R, Kanzaki S, Ogawa K, Kameyama K, Fujii M: Mucoepidermoid carcinoma of the head and neck: clinical analysis of 43 patients. Jpn J Clin Oncol; 2008 Jun;38(6):414-8
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucoepidermoid carcinoma of the head and neck: clinical analysis of 43 patients.
  • While the high-grade type is a highly aggressive tumor, its low-grade counterpart usually demonstrates a more benign nature and several systems have, therefore, been proposed to grade this neoplasm.
  • METHODS: This report analyzes 43 patients suffering from head and neck MEC, who were treated in our department during the period from 1989 to 2005.
  • [MeSH-major] Carcinoma, Mucoepidermoid / pathology. Carcinoma, Mucoepidermoid / therapy. Head and Neck Neoplasms / pathology. Head and Neck Neoplasms / therapy
  • [MeSH-minor] Adult. Age Factors. Aged. Aged, 80 and over. Analysis of Variance. Disease-Free Survival. Female. Humans. Kaplan-Meier Estimate. Male. Middle Aged. Neoplasm Staging. Predictive Value of Tests. Prognosis. Proportional Hazards Models. Radiotherapy, Adjuvant. Retrospective Studies. Salivary Gland Neoplasms / therapy. Sex Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Mucoepidermoid carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18573852.001).
  • [ISSN] 1465-3621
  • [Journal-full-title] Japanese journal of clinical oncology
  • [ISO-abbreviation] Jpn. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


41. Maev IV, Riazantsev AA, V'iuchnova ES: [Use of three-dimensional ultrasound visualization in differential diagnosis of pancreatic head diseases]. Klin Med (Mosk); 2009;87(10):67-72
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Use of three-dimensional ultrasound visualization in differential diagnosis of pancreatic head diseases].
  • Retrospective analysis of 3D-reconstruction of ultrasound images is discussed with reference to the diagnosis of pancreatic disorders, such as pseudotumorous pancreatitis and pancreatic head neoplasm, based on the data extracted from case records collected in the Central Clinical Hospital No 1, OJSC RZhD, for the period of 2004-2008.
  • Control group comprised 20 patients without signs of gastrointestinal pathology, group 2 included 24 patients with pseudotumorous pancreatitis, group 3 54 patients with pancreatic head neoplasm (up to 3 cm).
  • Also, it improves the quality of information about arterial and venous circulation and permits to differentiate between benign and malignant tumours.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20017357.001).
  • [ISSN] 0023-2149
  • [Journal-full-title] Klinicheskaia meditsina
  • [ISO-abbreviation] Klin Med (Mosk)
  • [Language] rus
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


42. O'Callaghan MG, House M, Ebay S, Bhadelia R: Rhabdomyoma of the head and neck demonstrated by prenatal magnetic resonance imaging. J Comput Assist Tomogr; 2005 Jan-Feb;29(1):130-2
MedlinePlus Health Information. consumer health - Prenatal Testing.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rhabdomyoma of the head and neck demonstrated by prenatal magnetic resonance imaging.
  • A case of fetal rhabdomyoma (myxoid type) of the head and neck demonstrated on prenatal magnetic resonance imaging (MRI) is presented.
  • This benign tumor of skeletal muscle is uncommon and should not be confused with its malignant counterpart-rhabdomyosarcoma.
  • With the increasing use of ultrafast MRI, the radiologist is more likely to encounter head and neck masses in the fetus.
  • [MeSH-major] Fetal Diseases / diagnosis. Head and Neck Neoplasms / diagnosis. Magnetic Resonance Imaging. Prenatal Diagnosis. Rhabdomyoma / diagnosis
  • [MeSH-minor] Adult. Female. Follow-Up Studies. Gestational Age. Humans. Infant, Newborn. Neoplasm Recurrence, Local / pathology. Pregnancy. Ultrasonography, Prenatal


43. Krestan C, Herneth AM, Formanek M, Czerny C: Modern imaging lymph node staging of the head and neck region. Eur J Radiol; 2006 Jun;58(3):360-6
Hazardous Substances Data Bank. HEMATITE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Modern imaging lymph node staging of the head and neck region.
  • The aim of this paper is to describe the modern imaging methods, their techniques, ability, and performance in staging head and neck lymph nodes.
  • Also, the imaging morphologies of benign and malignant lymph nodes according to the different imaging techniques will be delineated.
  • Imaging examples of the different modalities of benign and malignant transformed lymph nodes will be demonstrated.
  • Furthermore, the diagnostic sensitivity of each modality will be delineated and further aspects of modern lymph node staging of the head and neck region such as those with special contrast agents will be described.
  • Also the value of biopsy techniques including recently developed ultrasonography guided needle biopsy with molecular analysis of the cells of about 97-100% accuracy in diagnosing benign from malignant lymph nodes will be mentioned.
  • Overall, the reader will get an overview of the present imaging modalities to potentially stage correctly lymph nodes in the head and neck region to facilitate the therapeutic procedure.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Lymph Nodes / pathology
  • [MeSH-minor] Biopsy, Needle / methods. Contrast Media / administration & dosage. Diagnosis, Differential. Ferric Compounds. Humans. Image Enhancement / methods. Lymphatic Metastasis. Magnetic Resonance Imaging / methods. Medical Illustration. Neoplasm Staging. Sensitivity and Specificity. Tomography, X-Ray Computed / methods. Ultrasonography, Doppler, Color / methods

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • Hazardous Substances Data Bank. FERRIC OXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16687230.001).
  • [ISSN] 0720-048X
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Ferric Compounds; 1K09F3G675 / ferric oxide
  • [Number-of-references] 28
  •  go-up   go-down


44. Manfredi R, Graziani R, Motton M, Mantovani W, Baltieri S, Tognolini A, Crippa S, Capelli P, Salvia R, Pozzi Mucelli R: Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology; 2009 Oct;253(1):106-15
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis.
  • PURPOSE: To retrospectively determine the accuracy of magnetic resonance (MR) imaging combined with MR cholangiopancreatography (CP) in differentiating benign from malignant intraductal papillary mucinous neoplasms (IPMNs) involving the main pancreatic duct (MPD), with histopathologic analysis as the reference standard.
  • Qualitative image analysis included assessment of the site of MPD dilatation (head of the pancreas, body and/or tail of the pancreas, or diffuse), presence or absence of duct wall nodules, and contrast enhancement of the MPD walls.
  • MPD wall nodules were observed in 16 carcinomas involving the MPD and one adenoma or borderline neoplasm (P < .00001).
  • The median maximal diameter of the MPD was 18 mm in malignant MPD or mixed type IPMNs and 11 mm in benign borderline IPMNs (P = .038).

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19703865.001).
  • [ISSN] 1527-1315
  • [Journal-full-title] Radiology
  • [ISO-abbreviation] Radiology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Magnetite Nanoparticles; 0 / Siloxanes; 0 / ferumoxsil; XM0M87F357 / Ferrosoferric Oxide
  •  go-up   go-down


45. Kohl SK, Simpson RJ, Wisecarver J: Chondroid metaplasia mimicking recurrent squamous cell carcinoma of the head and neck. Ear Nose Throat J; 2009 Jan;88(1):E4
Genetic Alliance. consumer health - Carcinoma, Squamous Cell.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chondroid metaplasia mimicking recurrent squamous cell carcinoma of the head and neck.
  • She had a history of squamous cell carcinoma of the head and neck that had been treated with surgery and radiotherapy 11 years earlier.
  • The tongue lesion was excised, and pathologic examination identified a submucosal focus of benign-appearing cartilage.
  • Chondroid metaplasia involving the head and neck is rare.
  • [MeSH-major] Carcinoma, Squamous Cell / secondary. Neoplasm Recurrence, Local / pathology. Tongue Neoplasms / secondary. Tonsillar Neoplasms / pathology
  • [MeSH-minor] Aged. Biopsy, Needle. Cartilage / pathology. Combined Modality Therapy. Diagnosis, Differential. Female. Follow-Up Studies. Head and Neck Neoplasms / diagnosis. Head and Neck Neoplasms / therapy. Humans. Immunohistochemistry. Metaplasia / pathology. Neck Dissection / methods. Radiotherapy, Adjuvant. Risk Assessment. Tonsillectomy / methods

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19172559.001).
  • [ISSN] 1942-7522
  • [Journal-full-title] Ear, nose, & throat journal
  • [ISO-abbreviation] Ear Nose Throat J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


46. Razek AA: Diffusion-weighted magnetic resonance imaging of head and neck. J Comput Assist Tomogr; 2010 Nov-Dec;34(6):808-15
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diffusion-weighted magnetic resonance imaging of head and neck.
  • Our aim was to review the clinical applications of diffusion-weighted magnetic resonance imaging in the head and neck.
  • Diffusion-weighted magnetic resonance imaging plays a role in the differentiation of benign from malignant head and neck tumors, squamous cell carcinoma from lymphoma, and metastatic from benign lymphadenopathy as well as in the selection of the biopsy site.
  • [MeSH-major] Diffusion Magnetic Resonance Imaging / methods. Head and Neck Neoplasms / diagnosis
  • [MeSH-minor] Biopsy. Diagnosis, Differential. Echo-Planar Imaging. Humans. Image Enhancement / methods. Lymphatic Metastasis. Neoplasm Recurrence, Local / diagnosis. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21084893.001).
  • [ISSN] 1532-3145
  • [Journal-full-title] Journal of computer assisted tomography
  • [ISO-abbreviation] J Comput Assist Tomogr
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


47. Supriya M, Denholm S, Palmer T: Seeding of tumor cells after fine needle aspiration cytology in benign parotid tumor: a case report and literature review. Laryngoscope; 2008 Feb;118(2):263-5

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Seeding of tumor cells after fine needle aspiration cytology in benign parotid tumor: a case report and literature review.
  • We present to our knowledge the first case of tumor seeding after FNAC of a benign parotid tumor.
  • [MeSH-major] Adenoma, Pleomorphic / pathology. Biopsy, Fine-Needle / adverse effects. Neoplasm Seeding. Parotid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18030170.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 11
  •  go-up   go-down


48. Gourin CG, Watts T, Williams HT, Patel VS, Bilodeau PA, Coleman TA: Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer. Laryngoscope; 2009 Apr;119(4):703-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer.
  • OBJECTIVES: To investigate the utility of positron-emission tomography/computed tomography (PET-CT) in identifying distant metastatic disease in patients with suspected recurrent head and neck squamous cell cancer (HNSCC).
  • There was a significant correlation between standardized uptake value (SUV) on PET-CT and positive histology, with a mean SUV of 8.5 (range, 4.7-16.2) in patients with distant metastases compared with a mean SUV of 2.9 (range, 1.9-4.2) in patients with benign pathology (r = 0.87, P < .0001).
  • [MeSH-minor] Adult. Aged. Chemotherapy, Adjuvant. Female. Head and Neck Neoplasms / pathology. Head and Neck Neoplasms / surgery. Humans. Incidence. Male. Middle Aged. Neoplasm Recurrence, Local / radiography. Neoplasm Recurrence, Local / radionuclide imaging. Positron-Emission Tomography. Preoperative Care. Radiotherapy, Adjuvant. Retrospective Studies. Salvage Therapy. Sensitivity and Specificity. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19205017.001).
  • [ISSN] 1531-4995
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


49. Wu J, Rosenbaum E, Begum S, Westra WH: Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis. Am J Dermatopathol; 2007 Dec;29(6):534-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Distribution of BRAF T1799A(V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis.
  • The rate varied only slightly by anatomic site: BRAF mutations were detected in 21 of 21 (100%) nevi of the head and neck, 62 of 76 (82%) nevi of the trunk, 8 of 14 (62%) nevi of the extremities, and 18 of 24 (75%) anogenital nevi.
  • [MeSH-minor] Adolescent. Adult. Aged. Anus Neoplasms / genetics. Anus Neoplasms / pathology. Anus Neoplasms / surgery. Back / pathology. Child. DNA Mutational Analysis. DNA, Neoplasm / analysis. Extremities / pathology. Female. Head and Neck Neoplasms / genetics. Head and Neck Neoplasms / pathology. Head and Neck Neoplasms / surgery. Humans. Male. Microdissection. Middle Aged. Urogenital Neoplasms / genetics. Urogenital Neoplasms / pathology. Urogenital Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Moles.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18032947.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm; EC 2.7.11.1 / BRAF protein, human; EC 2.7.11.1 / Proto-Oncogene Proteins B-raf
  •  go-up   go-down


50. Duet M, Guichard JP, Rizzo N, Boudiaf M, Herman P, Tran Ba Huy P: Are somatostatin analogs therapeutic alternatives in the management of head and neck paragangliomas? Laryngoscope; 2005 Aug;115(8):1381-4
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Are somatostatin analogs therapeutic alternatives in the management of head and neck paragangliomas?
  • BACKGROUND: Although mostly benign, head and neck paragangliomas require active management because of injury to adjacent neurovascular structures.
  • [MeSH-major] Head and Neck Neoplasms / drug therapy. Octreotide / administration & dosage. Paraganglioma / drug therapy. Somatostatin / analogs & derivatives
  • [MeSH-minor] Adult. Dose-Response Relationship, Drug. Drug Administration Schedule. Female. Follow-Up Studies. Humans. Injections, Intramuscular. Male. Middle Aged. Neoplasm Staging. Predictive Value of Tests. Preoperative Care / methods. Prospective Studies. Risk Assessment. Tomography, X-Ray Computed. Treatment Outcome. Tumor Burden

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16094109.001).
  • [ISSN] 0023-852X
  • [Journal-full-title] The Laryngoscope
  • [ISO-abbreviation] Laryngoscope
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 51110-01-1 / Somatostatin; RWM8CCW8GP / Octreotide
  •  go-up   go-down


51. Pham NS, Poirier B, Fuller SC, Dublin AB, Tollefson TT: Pediatric lipoblastoma in the head and neck: a systematic review of 48 reported cases. Int J Pediatr Otorhinolaryngol; 2010 Jul;74(7):723-8
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pediatric lipoblastoma in the head and neck: a systematic review of 48 reported cases.
  • BACKGROUND: Lipoblastoma is an exceedingly rare cause of pediatric head and neck masses.
  • We present an additional case and review of the available literature on this rare neoplasm.
  • MEDLINE was searched for the terms "neonatal lipoblastoma", "lipoblastomatosis", and "benign lipoblastoma".
  • RESULTS: Including our new case, a total of 48 cases of head and neck lipoblastoma have been reported in the English literature within 23 manuscripts.
  • CONCLUSIONS: Our findings suggest that although total excision is ideal and curative, subtotal resection may be a viable treatment alternative for lipoblastoma of the head and neck.
  • Nonetheless, recurrence rates for head and neck lipoblastomas are similar to those rates observed elsewhere in the body.
  • [MeSH-major] Head and Neck Neoplasms / pathology. Lipoma / pathology
  • [MeSH-minor] Female. Humans. Infant. Infant, Newborn. Magnetic Resonance Imaging. Neoplasm Recurrence, Local. Respiratory Distress Syndrome, Newborn / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 20472310.001).
  • [ISSN] 1872-8464
  • [Journal-full-title] International journal of pediatric otorhinolaryngology
  • [ISO-abbreviation] Int. J. Pediatr. Otorhinolaryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Ireland
  •  go-up   go-down


52. Goshen E, Davidson T, Yahalom R, Talmi YP, Zwas ST: PET/CT in the evaluation of patients with squamous cell cancer of the head and neck. Int J Oral Maxillofac Surg; 2006 Apr;35(4):332-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PET/CT in the evaluation of patients with squamous cell cancer of the head and neck.
  • The purpose of this study was to compare the findings of positron emission tomography (PET) with fused PET and computed tomography (CT) in patients with suspected locoregional and distant head and neck cancer and to evaluate the impact of those findings on clinical management.
  • PET findings were classified as malignant, benign or equivocal.
  • The negative predictive value was 100% in this combined group of patients with locoregional and distant head and neck cancer.
  • PET/CT is highly contributory for initial staging and in the evaluation of patients with suspected recurrent SCC of the head and neck, in whom anatomic imaging is inconclusive due to the locoregional distortions rendered by surgery and radiotherapy.
  • [MeSH-major] Head and Neck Neoplasms / radiography. Head and Neck Neoplasms / radionuclide imaging. Neoplasm Recurrence, Local / radiography. Neoplasm Recurrence, Local / radionuclide imaging. Positron-Emission Tomography / methods. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16280234.001).
  • [ISSN] 0901-5027
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


53. Wang CP, Lee YC, Lou PJ, Yang TL, Chen TC, Huang CC, Ko JY: Unsedated transnasal esophagogastroduodenoscopy for the evaluation of dysphagia following treatment for previous primary head neck cancer. Oral Oncol; 2009 Jul;45(7):615-20
MedlinePlus Health Information. consumer health - Swallowing Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unsedated transnasal esophagogastroduodenoscopy for the evaluation of dysphagia following treatment for previous primary head neck cancer.
  • Dysphagia is not uncommon after curative treatment for primary head and neck cancer.
  • The purpose of this study was to prospectively investigate the diagnostic value of unsedated transnasal esophagogastroduodenoscopy (EGD) in 36 primary head and neck cancer patients with post-treatment dysphagia.
  • One patient had a benign tumor on the epiglottis and the other NPC patient had extensive soft tissue necrosis in the pyriform sinus as a cause of dysphagia.
  • [MeSH-major] Deglutition Disorders / diagnosis. Endoscopy, Digestive System / methods. Esophageal Neoplasms / diagnosis. Hypopharyngeal Neoplasms / diagnosis. Neoplasm Recurrence, Local / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Conscious Sedation. Feasibility Studies. Female. Head and Neck Neoplasms / pathology. Humans. Male. Middle Aged. Prospective Studies. Taiwan

  • Genetic Alliance. consumer health - Dysphagia.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19027351.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


54. Ferris RL, Xi L, Raja S, Hunt JL, Wang J, Gooding WE, Kelly L, Ching J, Luketich JD, Godfrey TE: Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck. Cancer Res; 2005 Mar 15;65(6):2147-56
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular staging of cervical lymph nodes in squamous cell carcinoma of the head and neck.
  • Clinical staging of cervical lymph nodes from patients with squamous cell carcinoma of the head and neck (SCCHN) has only 50% accuracy compared with definitive pathologic assessment.
  • Seven markers were identified with good characteristics for identifying metastatic disease, and these were validated using a set of 26 primary tumors, 19 histologically positive lymph nodes, and 21 benign nodes from patients without cancer.
  • Four markers discriminated between positive and benign nodes with accuracy >97% but only one marker, pemphigus vulgaris antigen (PVA), discriminated with 100% accuracy in both the observed data and a statistical bootstrap analysis.
  • The automated analysis with PVA provided perfect discrimination between histologically positive and benign lymph nodes and correctly identified two lymph nodes with micrometastatic tumor deposits.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Head and Neck Neoplasms / pathology. Lymph Nodes / pathology. Reverse Transcriptase Polymerase Chain Reaction / methods. Sentinel Lymph Node Biopsy / methods
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Neoplasm Staging

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15781625.001).
  • [ISSN] 0008-5472
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA90665-01
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


55. Fritz MA, Sade B, Bauer TW, Wood BG, Lee JH: Benign fibrous histiocytoma of the pterygopalatine fossa with intracranial extension. Acta Neurochir (Wien); 2006 Jan;148(1):73-6; discussion 76

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign fibrous histiocytoma of the pterygopalatine fossa with intracranial extension.
  • The benefit of multimodal therapy has not been established in these rare head and neck lesions.
  • [MeSH-major] Brain / pathology. Histiocytoma, Benign Fibrous / pathology. Neoplasm Recurrence, Local / pathology. Palate, Hard. Skull Base Neoplasms / pathology
  • [MeSH-minor] Fatal Outcome. Humans. Male. Middle Aged. Neoplasm Invasiveness

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16200478.001).
  • [ISSN] 0001-6268
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


56. Wang F, Wang Z, Yao W, Xie H, Xu J, Tian L: Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging. J Nucl Med; 2007 Sep;48(9):1442-8
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging.
  • The aim of this study was to evaluate the clinical value of tomographic (99m)Tc-octreotide acetate (hereafter, (99m)Tc-octreotide) scintigraphy in the detection of patients with suspected lung cancer in comparison with that of (18)F-FDG dual-head coincidence imaging (DHC).
  • Thirteen of the 44 patients had benign lung lesions.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Metastasis

  • Genetic Alliance. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17704242.001).
  • [ISSN] 0161-5505
  • [Journal-full-title] Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • [ISO-abbreviation] J. Nucl. Med.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 99mTc-octreotide; 0 / Organotechnetium Compounds; 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18; RWM8CCW8GP / Octreotide
  •  go-up   go-down


57. Roh JL, Ryu CH, Kim JS, Lee JS, Choi SH, Nam SY, Kim SY: Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer. Oral Oncol; 2007 Sep;43(8):757-63
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
  • Few studies have used positron emission tomography (PET) to identify metastases or simultaneous thoracic malignancies in patients with head and neck cancer (HNC).
  • Most of the lesions (83%) with abnormal FDG uptake were benign, with thoracic malignancy confirmed in 15 patients (17%).
  • [MeSH-major] Head and Neck Neoplasms / pathology. Lung Neoplasms / radionuclide imaging. Lung Neoplasms / secondary. Mediastinal Neoplasms / radionuclide imaging. Mediastinal Neoplasms / secondary. Positron-Emission Tomography
  • [MeSH-minor] Adolescent. Adult. Aged. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / radiography. Carcinoma, Squamous Cell / radionuclide imaging. Carcinoma, Squamous Cell / secondary. Female. Fluorodeoxyglucose F18. Humans. Image Interpretation, Computer-Assisted / methods. Male. Middle Aged. Neoplasm Staging. Radiopharmaceuticals. Retrospective Studies. Risk Factors. Sensitivity and Specificity. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17112773.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


58. Withrow KP, Newman JR, Skipper JB, Gleysteen JP, Magnuson JS, Zinn K, Rosenthal EL: Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts. Technol Cancer Res Treat; 2008 Feb;7(1):61-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts.
  • To determine the efficacy of fluorescently labeled anti-vascular endothelial growth factor (VEGF) antibody to be used as a cancer specific optical contrast agent to guide surgical resections, we evaluated the sensitivity and specificity of this agent to detect microscopic residual disease in a preclinical model of head and neck squamous cell carcinoma (HNSCC).
  • Samples taken from a non-fluorescing tumor bed (n=15) were found to be histologically benign in 11 of 15.
  • [MeSH-major] Antibodies, Monoclonal. Carbocyanines. Head and Neck Neoplasms / diagnosis. Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • [MeSH-minor] Animals. Antibodies, Monoclonal, Humanized. Bevacizumab. Humans. Male. Mice. Mice, SCID. Neoplasm Transplantation. Transplantation, Heterologous

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18198926.001).
  • [ISSN] 1533-0346
  • [Journal-full-title] Technology in cancer research & treatment
  • [ISO-abbreviation] Technol. Cancer Res. Treat.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA13148
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / CY5.5 cyanine dye; 0 / Carbocyanines; 0 / Vascular Endothelial Growth Factor A; 2S9ZZM9Q9V / Bevacizumab
  •  go-up   go-down


59. Durgun Y, Firat C, Miman MC, Kirimlioglu H: A rare benign laryngeal tumor: angiomyolipoma. J Craniofac Surg; 2010 Nov;21(6):1956-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A rare benign laryngeal tumor: angiomyolipoma.
  • Angiomyolipoma is a mesenchymal neoplasm containing adipose tissue, blood vessels, and smooth muscle fibers.
  • Arising most frequently in the kidney, the tumor may exceptionally be at the head and neck region.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21119467.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


60. Muenscher A, Diegel T, Jaehne M, Ussmüller J, Koops S, Sanchez-Hanke M: Benign and malignant salivary gland diseases in children A retrospective study of 549 cases from the Salivary Gland Registry, Hamburg. Auris Nasus Larynx; 2009 Jun;36(3):326-31
MedlinePlus Health Information. consumer health - Salivary Gland Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign and malignant salivary gland diseases in children A retrospective study of 549 cases from the Salivary Gland Registry, Hamburg.
  • Most of the specimens were presented by the Clinic for Otorhinolaryngology and Head and Neck Surgery, University Hamburg, Eppendorf.
  • [MeSH-minor] Adolescent. Biopsy. Catchment Area (Health). Child. Child, Preschool. Female. Germany / epidemiology. Humans. Infant. Infant, Newborn. Male. Neoplasm Staging. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18809268.001).
  • [ISSN] 1879-1476
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


61. Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, Hany TF: Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT. Eur J Nucl Med Mol Imaging; 2009 Jun;36(6):919-27
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.
  • PURPOSE: The aim of the study was to evaluate (18)F-FDG-PET/CT for the detection of synchronous primaries at initial staging of patients with head and neck squamous cell carcinoma (HNSCC).
  • Of the 56 second cancers, 46 (82%) were found in the aerodigestive tract in the following locations: lung (26, 46%), head and neck (15, 17%), oesophagus (5, 9%).
  • Nine synchronous cancers were not detected by PET/CT (four head and neck, two lung, two oesophageal, one gastric).
  • False-positive PET/CT findings were mainly related to benign FDG uptake in the intestine due to benign or precancerous polyps or physiological FDG uptake in other head and neck regions.
  • Synchronous cancers were predominantly located in the aerodigestive tract, primarily in the lung, head and neck and oesophagus.
  • [MeSH-major] Fluorodeoxyglucose F18. Head and Neck Neoplasms / diagnostic imaging. Neoplasms, Multiple Primary / diagnostic imaging. Neoplasms, Squamous Cell / diagnostic imaging
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. False Positive Reactions. Female. Humans. Male. Middle Aged. Neoplasm Staging. Neoplasms, Second Primary / diagnostic imaging. Neoplasms, Second Primary / pathology. Neoplasms, Second Primary / therapy. Positron-Emission Tomography. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Otolaryngol Head Neck Surg. 2003 Nov;129(11):1173-8 [14623746.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2002 Jun;128(6):703-7 [12049568.001]
  • [Cites] Head Neck. 2002 Apr;24(4):345-9 [11933176.001]
  • [Cites] Neuroradiology. 2008 Nov;50(11):969-79 [18600319.001]
  • [Cites] Radiother Oncol. 2008 May;87(2):221-9 [18410977.001]
  • [Cites] Otolaryngol Head Neck Surg. 2001 Feb;124(2):208-12 [11226943.001]
  • [Cites] Otolaryngol Head Neck Surg. 2007 Jul;137(1):130-7 [17599580.001]
  • [Cites] Head Neck. 2007 Nov;29(11):986-95 [17563906.001]
  • [Cites] Head Neck. 1989 Sep-Oct;11(5):426-30 [2807882.001]
  • [Cites] J Nucl Med. 2004 Nov;45(11):1804-10 [15534047.001]
  • [Cites] J Comput Assist Tomogr. 1999 Jul-Aug;23 (4):603-8 [10433294.001]
  • [Cites] Cancer. 1995 Mar 15;75(6):1343-53 [7882285.001]
  • [Cites] Am J Surg. 1987 Oct;154(4):434-8 [3661848.001]
  • [Cites] Nucl Med Commun. 2005 Aug;26(8):671-87 [16000985.001]
  • [Cites] Oral Oncol. 2006 Mar;42(3):275-80 [16266820.001]
  • [Cites] Laryngoscope. 2007 Jul;117(7):1173-9 [17603315.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):467-76 [2674075.001]
  • [Cites] Laryngoscope. 2003 May;113(5):888-91 [12792328.001]
  • [Cites] Ann Nucl Med. 2006 Nov;20(9):597-604 [17294670.001]
  • [Cites] Oral Oncol. 2003 Sep;39(6):547-51 [12798396.001]
  • [Cites] Cancer. 1953 Sep;6(5):963-8 [13094644.001]
  • [Cites] Am J Surg. 1964 Oct;108:552-7 [14211447.001]
  • [Cites] AJR Am J Roentgenol. 2004 May;182(5):1129-32 [15100107.001]
  • (PMID = 19205699.001).
  • [ISSN] 1619-7089
  • [Journal-full-title] European journal of nuclear medicine and molecular imaging
  • [ISO-abbreviation] Eur. J. Nucl. Med. Mol. Imaging
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


62. Hafidh MA, Lacy PD, Hughes JP, Duffy G, Timon CV: Evaluation of the impact of addition of PET to CT and MR scanning in the staging of patients with head and neck carcinomas. Eur Arch Otorhinolaryngol; 2006 Sep;263(9):853-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of the impact of addition of PET to CT and MR scanning in the staging of patients with head and neck carcinomas.
  • The addition of whole body positron emission tomography (PET) to the investigation of patients with newly diagnosed head and neck squamous cell carcinoma (HNSCC) was assessed over a 6-month period.
  • SUV levels above 5 were considered indicative of the presence of tumour, values below 3 indicative of benign aetiology and values equal to and between 3 and 5 were considered equivocal.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Head and Neck Neoplasms / pathology. Magnetic Resonance Imaging / methods. Positron-Emission Tomography / methods. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. Neoplasm Staging. Prospective Studies. ROC Curve. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Otolaryngol Head Neck Surg. 2003 Nov;129(11):1173-8 [14623746.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2002 Jun;128(6):703-7 [12049568.001]
  • [Cites] Head Neck. 2000 Mar;22(2):105-10 [10679897.001]
  • [Cites] AJR Am J Roentgenol. 1997 Dec;169(6):1663-9 [9393187.001]
  • [Cites] Radiology. 2004 Apr;231(1):65-72 [14990824.001]
  • [Cites] Head Neck. 2002 Apr;24(4):345-9 [11933176.001]
  • [Cites] BMJ. 1994 Jul 16;309(6948):188 [8044101.001]
  • [Cites] J Laryngol Otol. 2002 Mar;116(3):194-9 [11893261.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1295-300 [15275712.001]
  • [Cites] J Nucl Med. 1995 Oct;36(10 ):1747-57 [7562038.001]
  • [Cites] J Nucl Med. 1995 Feb;36(2):211-6 [7830116.001]
  • [Cites] Radiology. 1999 Jan;210(1):177-81 [9885604.001]
  • [Cites] Laryngoscope. 1995 Feb;105(2):135-9 [8544591.001]
  • [Cites] Head Neck. 1998 Dec;20(8):739-44 [9790297.001]
  • [Cites] Laryngoscope. 1992 Mar;102(3):281-8 [1545657.001]
  • [Cites] Otolaryngol Head Neck Surg. 2000 Sep;123(3):294-301 [10964310.001]
  • [Cites] Radiology. 1993 Jan;186(1):27-35 [8416578.001]
  • [Cites] Laryngoscope. 1995 Apr;105(4 Pt 1):373-5 [7715380.001]
  • [Cites] Oral Oncol. 1999 Jul;35(4):390-4 [10645404.001]
  • [Cites] Nuklearmedizin. 2004 Jun;43(3):91-101;quiz 102-4 [15201950.001]
  • [Cites] J Otolaryngol. 2005 Dec;34(6):384-94 [16343398.001]
  • [Cites] Head Neck. 1996 Nov-Dec;18(6):545-51 [8902568.001]
  • [Cites] Head Neck. 2005 Jun;27(6):494-502 [15772951.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1993;250(1):11-7 [8466744.001]
  • [Cites] Clin Otolaryngol Allied Sci. 1994 Feb;19(1):63-9 [8174305.001]
  • [Cites] Radiology. 2005 May;235(2):580-6 [15858097.001]
  • [Cites] J Nucl Med. 2004 Aug;45(8):1328-33 [15299057.001]
  • [Cites] Head Neck. 2003 Feb;25(2):138-45 [12509797.001]
  • (PMID = 16724209.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


63. Aarstad HJ, Aarstad AK, Heimdal JH, Olofsson J: Mood, anxiety and sense of humor in head and neck cancer patients in relation to disease stage, prognosis and quality of life. Acta Otolaryngol; 2005 May;125(5):557-65
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mood, anxiety and sense of humor in head and neck cancer patients in relation to disease stage, prognosis and quality of life.
  • OBJECTIVE: To study the association between anxiety score, depression level at sense of humor at diagnosis in head and neck squamous cell carcinoma (HNSCC) patients versus TNM stage, prognosis and depression level/quality of life (QOL) 6 years following diagnosis.
  • A control group of patients with benign HN disease was also included.
  • MATERIAL AND METHODS: Male patients with newly diagnosed HNSCC (n =78) or benign HN (n =61) disease completed the following questionnaires: the Beck Depression Inventory, the Spielberger Trait Anxiety Inventory (state) and the Svebak humor questionnaire.
  • [MeSH-minor] Female. Humans. Male. Middle Aged. Neoplasm Staging. Psychometrics. Quality of Life. Severity of Illness Index


64. Rahbari R, Sansano IG, Elaraj DM, Duh QY, Clark OH, Kebebew E: Prior head and neck radiation exposure is not a contraindication to minimally invasive parathyroidectomy. J Am Coll Surg; 2010 Jun;210(6):942-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prior head and neck radiation exposure is not a contraindication to minimally invasive parathyroidectomy.
  • In patients with a history of head and neck irradiation, due to the increased risk of multigland disease and risk of concurrent thyroid cancer, minimally invasive parathyroidectomy is considered by some to be a contraindication.
  • We postulated that previous history of head and neck irradiation should not be a contraindication for minimally invasive parathyroidectomy and tested this hypothesis in a prospective cohort of patients undergoing parathyroidectomy for primary hyperparathyroidism.
  • RESULTS: Fifty-two (12.6%) patients had a history of head and neck irradiation and 360 (87.4%) had no exposure to radiation.
  • There was no significant difference in concurrent benign thyroid neoplasm, thyroid cancer, and type of parathyroid disease (single vs multigland) in the 2 groups.
  • CONCLUSIONS: Head and neck irradiation should not be a contraindication for minimally invasive parathyroidectomy in patients with primary hyperparathyroidism in the setting of preoperative localization studies showing single-gland disease and no concurrent thyroid neoplasm.
  • Furthermore, history of head and neck irradiation is associated with a later age of presentation for parathyroidectomy.
  • [MeSH-major] Head and Neck Neoplasms / radiotherapy. Hyperparathyroidism, Primary / surgery. Parathyroidectomy. Radiotherapy. Thyroid Neoplasms / radiotherapy

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Radiation Therapy.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by Elsevier Inc.
  • (PMID = 20510803.001).
  • [ISSN] 1879-1190
  • [Journal-full-title] Journal of the American College of Surgeons
  • [ISO-abbreviation] J. Am. Coll. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


65. Vranic S, Caughron SK, Djuricic S, Bilalovic N, Zaman S, Suljevic I, Lydiatt WM, Emanuel J, Gatalica Z: Hamartomas, teratomas and teratocarcinosarcomas of the head and neck: Report of 3 new cases with clinico-pathologic correlation, cytogenetic analysis, and review of the literature. BMC Ear Nose Throat Disord; 2008;8:8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hamartomas, teratomas and teratocarcinosarcomas of the head and neck: Report of 3 new cases with clinico-pathologic correlation, cytogenetic analysis, and review of the literature.
  • The head and neck region including the upper respiratory tract is a very rare location for such tumors in both children and adults, which can cause diagnostic and therapeutic difficulties.
  • METHODS: We describe here two new cases of multilineage tumors including sinonasal teratocarcinosarcoma [SNTCS], and congenital oronasopharyngeal teratoma (epignathus) and compare their features with those of a new case of a rare salivary gland anlage tumor [SGAT], an entity for which the pathogenesis is unclear (i.e. hamartoma versus neoplasm).
  • Both cytogenetic abnormalities are characteristically present in malignant germ cell tumors providing for the first time evidence that this rare tumor type indeed might represent a variant of a germ cell neoplasm.
  • The SGAT and epignathus carried no such cytogenetic abnormalities, in keeping with their limited and benign biologic potential.
  • Malignant tumors of germ cell origins are more likely to affect adults with insidious symptom development, while benign tumors can nevertheless cause dramatic clinical symptoms which, under certain circumstances, can be fatal.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Fetal Diagn Ther. 2003 Jan-Feb;18(1):26-8 [12566771.001]
  • [Cites] Pediatrics. 2003 Jul;112(1 Pt 1):e66-9 [12837908.001]
  • [Cites] Pathol Int. 2000 Jan;50(1):71-5 [10692182.001]
  • [Cites] Cancer Genet Cytogenet. 1999 Nov;115(1):1-10 [10565292.001]
  • [Cites] Ann Diagn Pathol. 2008 Dec;12(6):415-25 [18995206.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2008 Jun;134(6):592-5 [18559724.001]
  • [Cites] Br J Oral Maxillofac Surg. 2008 Jun;46(4):317-9 [17716791.001]
  • [Cites] Hum Pathol. 2008 Apr;39(4):605-9 [18284932.001]
  • [Cites] Zhonghua Bing Li Xue Za Zhi. 2007 Aug;36(8):534-8 [17980101.001]
  • [Cites] Br J Oral Maxillofac Surg. 2007 Jun;45(4):326-7 [16377040.001]
  • [Cites] Cancer Genet Cytogenet. 2007 Apr 1;174(1):68-73 [17350470.001]
  • [Cites] Ann Diagn Pathol. 2006 Dec;10(6):339-42 [17126251.001]
  • [Cites] J Matern Fetal Neonatal Med. 2006 Jun;19(6):377-9 [16801317.001]
  • [Cites] Genes Chromosomes Cancer. 2006 Nov;45(11):995-1006 [16897744.001]
  • [Cites] Nat Rev Cancer. 2005 Mar;5(3):210-22 [15738984.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2005 Feb;69(2):149-56 [15656947.001]
  • [Cites] Radiographics. 2005 Jan-Feb;25(1):215-42 [15653597.001]
  • [Cites] Histopathology. 1998 Jan;32(1):84 [9522222.001]
  • [Cites] Genes Chromosomes Cancer. 1999 Jun;25(2):134-46 [10337997.001]
  • [Cites] J Pediatr Surg. 1998 Mar;33(3):520-1 [9537572.001]
  • [Cites] Pathology. 1996 May;28(2):128-30 [8743816.001]
  • [Cites] Pathol Res Pract. 1995 Mar;191(2):166-71; discussion 172-3 [7567686.001]
  • [Cites] Cancer Genet Cytogenet. 1994 Jul 15;75(2):90-102 [8055486.001]
  • [Cites] Am J Surg Pathol. 1994 Jan;18(1):25-36 [8279626.001]
  • [Cites] Prenat Diagn. 1993 Oct;13(10):945-52 [8309901.001]
  • [Cites] Plast Reconstr Surg. 1993 Feb;91(2):223-8 [8430136.001]
  • [Cites] Acta Otorrinolaringol Esp. 1991 Sep-Oct;42(5):363-7 [1816798.001]
  • [Cites] J Laryngol Otol. 1985 Dec;99(12):1281-7 [2999276.001]
  • [Cites] Cancer. 1984 May 15;53(10):2140-54 [6322958.001]
  • [Cites] Pediatr Blood Cancer. 2004 Nov;43(6):687-91 [15390296.001]
  • [Cites] J Oral Maxillofac Surg. 2004 Mar;62(3):379-83 [15015174.001]
  • [Cites] Pediatr Surg Int. 2003 Sep;19(7):509-19 [14523568.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2002 Feb 1;62(2):159-64 [11788149.001]
  • (PMID = 19025657.001).
  • [ISSN] 1472-6815
  • [Journal-full-title] BMC ear, nose, and throat disorders
  • [ISO-abbreviation] BMC Ear Nose Throat Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2611960
  •  go-up   go-down


66. Ma C, Quesnelle KM, Sparano A, Rao S, Park MS, Cohen MA, Wang Y, Samanta M, Kumar MS, Aziz MU, Naylor TL, Weber BL, Fakharzadeh SS, Weinstein GS, Vachani A, Feldman MD, Brose MS: Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer Biol Ther; 2009 May;8(10):907-16
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues.
  • The Cub and Sushi Multiple Domains-1 (CSMD1) is a tumor suppressor gene on 8p23.2, where allelic loss is both frequent and associated with poor prognosis in head and neck squamous cell carcinoma (HNSCC).
  • To understand the extent of CSMD1 aberrations in vivo, we characterized 184 primary tumors from the head and neck, lung, breast and skin for gene copy number and analyzed expression in our HNSCCs and lung squamous cell carcinomas (SCCs).
  • CSMD1 expression was decreased in tumors compared to adjacent benign tissue (65%, 13/20) and was likely due to gene loss in 45% of cases (9/20).
  • [MeSH-major] Breast Neoplasms / genetics. Head and Neck Neoplasms / genetics. Lung Neoplasms / genetics. Membrane Proteins / genetics. Skin Neoplasms / genetics
  • [MeSH-minor] Carcinoma, Squamous Cell / genetics. Carcinoma, Squamous Cell / pathology. Case-Control Studies. Chromosome Deletion. Comparative Genomic Hybridization. DNA, Neoplasm / analysis. Female. Gene Dosage. Gene Expression. Humans. Loss of Heterozygosity. Mouth Neoplasms / genetics. RNA, Messenger / genetics. RNA, Messenger / metabolism


67. Tatomirovic Z, Skuletic V, Bokun R, Trimcev J, Radic O, Cerovic S, Strbac M, Zolotarevski L, Tukic Lj, Stamatovic D, Tarabar O: Fine needle aspiration cytology in the diagnosis of head and neck masses: accuracy and diagnostic problems. J BUON; 2009 Oct-Dec;14(4):653-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fine needle aspiration cytology in the diagnosis of head and neck masses: accuracy and diagnostic problems.
  • PURPOSE: Fine needle aspiration (FNA) cytology is an established technique associated with minimal complications compared with more invasive techniques such as wide core needle biopsy or open biopsy, and as such, very suitable for obtaining material in the delicate region of head and neck (H&N).
  • The overall accuracy rate of FNA cytology, whether malignant or benign, was 91.89%, while the diagnostic accuracy for the exact type of tumor was 87.16%.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Lymphoma / diagnosis. Pseudolymphoma / diagnosis
  • [MeSH-minor] Adenocarcinoma / diagnosis. Adenocarcinoma / secondary. Biopsy, Fine-Needle. Biopsy, Needle. Carcinoma, Small Cell / diagnosis. Carcinoma, Small Cell / secondary. Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / secondary. Cytological Techniques. Diagnosis, Differential. Diagnostic Errors. Humans. Neoplasm Staging. Prognosis. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Lymphoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20148458.001).
  • [ISSN] 1107-0625
  • [Journal-full-title] Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • [ISO-abbreviation] J BUON
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  •  go-up   go-down


68. Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, Hamilton K, Singal R, Goodwin WJ: Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev; 2007 Jul;16(7):1348-55
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Soluble CD44 is a potential marker for the early detection of head and neck cancer.
  • INTRODUCTION: Head and neck squamous cell carcinoma (HNSCC) is a devastating and deadly disease, largely because it is diagnosed in late stage.
  • In this study, we evaluate soluble CD44 (solCD44) as an early detection tool for HNSCC by determining whether it reliably distinguishes HNSCC from benign disease of the upper aerodigestive tract.
  • METHODS: We carried out the solCD44 ELISA on oral rinses from 102 patients with HNSCC and 69 control patients with benign diseases of upper aerodigestive tract to determine the sensitivity and specificity of the test for differentiating HNSCC from benign disease.
  • Furthermore, we did a pilot study using methylation-specific PCR primers on oral rinses from 11 HNSCC patients with low solCD44 levels and 10 benign disease controls.
  • RESULTS: Mean salivary solCD44 levels were 24.4 +/- 32.0 ng/mL for HNSCC patients (range, 0.99-201 ng/mL) and 9.9 +/- 16.1 ng/mL (range, 0.73-124 ng/mL) for the patients with benign disease (P < 0.0001).
  • CONCLUSIONS: SolCD44 is elevated in the majority of HNSCC and distinguishes cancer from benign disease with high specificity.
  • [MeSH-major] Antigens, CD44 / metabolism. Biomarkers, Tumor / metabolism. Carcinoma, Squamous Cell / metabolism. Head and Neck Neoplasms / metabolism
  • [MeSH-minor] Case-Control Studies. DNA Methylation. Enzyme-Linked Immunosorbent Assay. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / metabolism. Neoplasm Recurrence, Local / pathology. Neoplasm Staging. Pilot Projects. Prognosis. Saliva / metabolism. Sensitivity and Specificity

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17627000.001).
  • [ISSN] 1055-9965
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA107828
  • [Publication-type] Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / Biomarkers, Tumor; 0 / CD44 protein, human
  •  go-up   go-down


69. Wu J, Crimmins JT, Monk KR, Williams JP, Fitzgerald ME, Tedesco S, Ratner N: Perinatal epidermal growth factor receptor blockade prevents peripheral nerve disruption in a mouse model reminiscent of benign world health organization grade I neurofibroma. Am J Pathol; 2006 May;168(5):1686-96
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Perinatal epidermal growth factor receptor blockade prevents peripheral nerve disruption in a mouse model reminiscent of benign world health organization grade I neurofibroma.
  • Benign peripheral nerve tumors called neurofibromas are a major source of morbidity for patients with neurofibromatosis type 1.

  • Hazardous Substances Data Bank. CETUXIMAB .
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Exp Dermatol. 2003 Aug;12(4):412-7 [12930297.001]
  • [Cites] Neuron. 1999 Jun;23(2):273-83 [10399934.001]
  • [Cites] Br J Cancer. 2004 Apr 19;90(8):1679-85 [15083203.001]
  • [Cites] N Engl J Med. 2004 Jul 22;351(4):337-45 [15269313.001]
  • [Cites] Proc Natl Acad Sci U S A. 1983 Mar;80(5):1337-41 [6298788.001]
  • [Cites] Cancer. 1986 Mar 15;57(6):1225-9 [3080222.001]
  • [Cites] Cell. 1990 Apr 20;61(2):203-12 [2158859.001]
  • [Cites] J Dermatol Sci. 1992 May;3(3):137-44 [1498092.001]
  • [Cites] J Clin Pathol. 1993 Jan;46(1):86-7 [8432898.001]
  • [Cites] Cancer Res. 1993 Sep 15;53(18):4322-8 [8364927.001]
  • [Cites] Biochem Biophys Res Commun. 1994 Feb 15;198(3):827-34 [8117287.001]
  • [Cites] Genes Dev. 1994 May 1;8(9):1019-29 [7926784.001]
  • [Cites] Arch Dermatol Res. 1999 Jun;291(6):318-24 [10421057.001]
  • [Cites] Am J Med Genet. 1999 Mar 26;89(1):1-6 [10469430.001]
  • [Cites] Am J Med Genet. 1999 Mar 26;89(1):31-7 [10469434.001]
  • [Cites] J Invest Dermatol. 1999 Sep;113(3):398-402 [10469340.001]
  • [Cites] Cancer Gene Ther. 1999 Sep-Oct;6(5):423-7 [10505852.001]
  • [Cites] Cancer Cell. 2005 Jan;7(1):65-75 [15652750.001]
  • [Cites] Oncogene. 2005 Aug 25;24(36):5589-605 [15897877.001]
  • [Cites] Science. 1999 Dec 10;286(5447):2172-6 [10591652.001]
  • [Cites] Science. 1999 Dec 10;286(5447):2176-9 [10591653.001]
  • [Cites] Oncogene. 1999 Nov 11;18(47):6513-20 [10597254.001]
  • [Cites] J Clin Oncol. 2000 Feb;18(4):904-14 [10673534.001]
  • [Cites] J Clin Invest. 2000 May;105(9):1233-41 [10791998.001]
  • [Cites] Cell. 2000 Oct 13;103(2):211-25 [11057895.001]
  • [Cites] Oncogene. 2001 Jan 4;20(1):97-105 [11244508.001]
  • [Cites] Oncogene. 2000 Dec 27;19(56):6550-65 [11426640.001]
  • [Cites] Clin Cancer Res. 2001 Oct;7(10):2958-70 [11595683.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1521-6 [11818567.001]
  • [Cites] Head Neck. 2002 Feb;24(2):207-11 [11891951.001]
  • [Cites] Science. 2002 May 3;296(5569):920-2 [11988578.001]
  • [Cites] Clin Cancer Res. 2002 May;8(5):1253-64 [12006546.001]
  • [Cites] Neurology. 2002 May 28;58(10):1461-70 [12041525.001]
  • [Cites] J Neuropathol Exp Neurol. 2002 Aug;61(8):702-9 [12152785.001]
  • [Cites] Cancer Res. 2002 Aug 1;62(15):4507-13 [12154062.001]
  • [Cites] J Dermatol. 2002 Nov;29(11):713-7 [12484433.001]
  • [Cites] J Gastrointest Surg. 2003 Jan;7(1):37-43; discussion 43 [12559183.001]
  • [Cites] Mol Cell Biol. 2003 Mar;23(6):2213-24 [12612091.001]
  • [Cites] J Neurosci. 1994 Dec;14(12):7284-90 [7996175.001]
  • [Cites] Crit Rev Oncol Hematol. 1995 Jul;19(3):183-232 [7612182.001]
  • [Cites] J Neurosci. 1996 Oct 1;16(19):6107-18 [8815893.001]
  • [Cites] Pain. 1996 Aug;66(2-3):265-70 [8880849.001]
  • [Cites] Am J Hum Genet. 1997 Sep;61(3):512-9 [9326316.001]
  • [Cites] J Pediatr. 1997 Nov;131(5):678-82 [9403645.001]
  • [Cites] Ann Med. 1997 Dec;29(6):531-4 [9562519.001]
  • [Cites] J Exp Med. 1998 Jun 1;187(11):1893-902 [9607929.001]
  • [Cites] Clin Cancer Res. 1995 Nov;1(11):1311-8 [9815926.001]
  • [Cites] Biochem Pharmacol. 1999 Apr 15;57(8):917-25 [10086326.001]
  • [Cites] Brain. 1999 Mar;122 ( Pt 3):473-81 [10094256.001]
  • [Cites] Cancer Res. 1999 Mar 15;59(6):1236-43 [10096554.001]
  • [Cites] Nat Neurosci. 2003 Nov;6(11):1186-93 [14555954.001]
  • (PMID = 16651634.001).
  • [ISSN] 0002-9440
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] ENG
  • [Grant] United States / NINDS NIH HHS / NS / R01 NS028840; United States / NCI NIH HHS / CA / T32 CA059268; United States / NINDS NIH HHS / NS / NS28840; United States / NCI NIH HHS / CA / T32-CA-59268
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antibodies, Monoclonal, Humanized; 0 / Antineoplastic Agents; 0 / Chemotactic Factors; 0 / Fibroblast Growth Factor 9; 0 / Neurofibromin 1; 0 / Oncogene Proteins v-fos; EC 2.7.10.1 / Receptor, Epidermal Growth Factor; EC 3.1.4.- / 2',3'-Cyclic-Nucleotide Phosphodiesterases; PQX0D8J21J / Cetuximab
  • [Other-IDs] NLM/ PMC1606591
  •  go-up   go-down


70. Prenzel KL, Hölscher AH, Vallböhmer D, Drebber U, Gutschow CA, Mönig SP, Stippel DL: Lymph node size and metastatic infiltration in adenocarcinoma of the pancreatic head. Eur J Surg Oncol; 2010 Oct;36(10):993-6
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Lymph node size and metastatic infiltration in adenocarcinoma of the pancreatic head.
  • BACKGROUND: Preoperative lymph node staging of pancreatic cancer by CT relies on the premise that malignant lymph nodes are larger than benign nodes.
  • [MeSH-minor] Adult. Aged. Cohort Studies. Confidence Intervals. Female. Humans. Kaplan-Meier Estimate. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Invasiveness / pathology. Neoplasm Staging. Pancreatectomy / methods. Pancreatectomy / mortality. Prognosis. Retrospective Studies. Risk Assessment. Survival Analysis. Treatment Outcome. Tumor Burden

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20594789.001).
  • [ISSN] 1532-2157
  • [Journal-full-title] European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • [ISO-abbreviation] Eur J Surg Oncol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  •  go-up   go-down


71. Bei R, Masuelli L, Trono P, Orvietani PL, Losito S, Marzocchella L, Vitolo D, Albonici L, Mrozek MA, Di Gennaro E, Lista F, Faggioni G, Ionna F, Binaglia L, Manzari V, Budillon A, Modesti A: The ribosomal P0 protein induces a spontaneous immune response in patients with head and neck advanced stage carcinoma that is not dependent on its overexpression in carcinomas. Int J Oncol; 2007 Dec;31(6):1301-8
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The ribosomal P0 protein induces a spontaneous immune response in patients with head and neck advanced stage carcinoma that is not dependent on its overexpression in carcinomas.
  • In this report we provide evidence for the in vivo immunogenicity of the P0 protein in head and neck cancer patients as well as overexpression by immunohistochemistry of the C-22 P0 epitope in invasive carcinomas (55/57).
  • Overexpression of this epitope was also significantly associated with a number of pathological lesions arising in the head and neck stratified epithelium including acanthosis (8/8), benign tumors (11/11), dysplasia (23/25) and in situ carcinomas (9/9).
  • Evidence for immunity to the P0 protein, as well as overexpression in patients with head and neck carcinoma may be relevant for monitoring cancer progression, in planning immunotherapeutic strategies, and contribute to the understanding of immuno-biological behaviour of head and neck carcinomas.
  • [MeSH-major] Carcinoma, Squamous Cell / immunology. Head and Neck Neoplasms / immunology. Ribosomal Proteins / immunology
  • [MeSH-minor] Amino Acid Sequence. Antibodies / blood. Antibodies, Monoclonal / immunology. Cell Line, Tumor. Epitopes. Humans. Molecular Sequence Data. Neoplasm Staging

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17982655.001).
  • [ISSN] 1019-6439
  • [Journal-full-title] International journal of oncology
  • [ISO-abbreviation] Int. J. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antibodies; 0 / Antibodies, Monoclonal; 0 / Epitopes; 0 / Ribosomal Proteins; 0 / ribosomal protein P0
  •  go-up   go-down


72. Agarwal B, Krishna NB, Labundy JL, Safdar R, Akduman EI: EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct. Gastrointest Endosc; 2008 Aug;68(2):237-42; quiz 334, 335
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] EUS and/or EUS-guided FNA in patients with CT and/or magnetic resonance imaging findings of enlarged pancreatic head or dilated pancreatic duct with or without a dilated common bile duct.
  • BACKGROUND: Incidental findings of an enlarged head of pancreas (HOP) or dilated pancreatic duct (PD) with or without a dilated common bile duct (CBD) on CT or magnetic resonance imaging (MRI), in patients without obstructive jaundice, raise suspicion for a pancreatic neoplasm, but their clinical significance has not been established.
  • OBJECTIVE: To determine the prevalence of pancreatic neoplasm in this patient group.
  • (1) The prevalence of pancreatic neoplasms and (2) performance characteristics of EUS-FNA for identifying malignant neoplasm, in this patient group.
  • RESULTS: In 110 study patients, the final diagnosis included adenocarcinoma (n = 7), pancreatic intraepithelial neoplasia (n = 1), neuroendocrine tumor (n = 1), tumor metastasis (n = 1), and benign cyst (n = 3).
  • The accuracy of EUS and EUS-FNA for diagnosing pancreatic neoplasm in these patients was 99.1%, with 88.8% sensitivity, 100% specificity, 99% negative predicative value, and 100% positive predictive value.
  • CONCLUSION: A pancreatic neoplasm is seen in a clinically significant number of patients with "enlarged HOP" or "dilated PD with or without a dilated CBD" but without obstructive jaundice.
  • EUS-FNA seems highly accurate for diagnosing pancreatic neoplasm in these patients.

  • MedlinePlus Health Information. consumer health - Diagnostic Imaging.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Endoscopy. 2010 Jan;42(1):68-72 [20066593.001]
  • (PMID = 18423464.001).
  • [ISSN] 1097-6779
  • [Journal-full-title] Gastrointestinal endoscopy
  • [ISO-abbreviation] Gastrointest. Endosc.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


73. Kross KW, Heimdal JH, Olsnes C, Olofsson J, Aarstad HJ: Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density. Acta Otolaryngol; 2005 Oct;125(10):1097-104
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Head and neck squamous cell carcinoma spheroid- and monocyte spheroid-stimulated IL-6 and monocyte chemotactic protein-1 secretion are related to TNM stage, inflammatory state and tumor macrophage density.
  • Monocyte fragment (F)-spheroid-stimulated and F-spheroid IL-6 and monocyte chemotactic protein (MCP)-1 secretion are related to inflammatory state, macrophage density and the TNM stage of patients with head and neck squamous cell carcinoma (HNSCC).
  • Malignant (M) F-spheroids secreted more MCP-1 than benign (B) F-spheroids.
  • [MeSH-major] Carcinoma, Squamous Cell / secretion. Chemokine CCL2 / secretion. Head and Neck Neoplasms / secretion. Interleukin-6 / secretion. Monocytes / secretion. Spheroids, Cellular / secretion
  • [MeSH-minor] Blood Sedimentation. Cell Count. Coculture Techniques. Humans. Macrophages. Neoplasm Staging. Tumor Cells, Cultured. Tumor Necrosis Factor-alpha / secretion


74. Sandison A: Common head and neck cases in our consultation referrals: diagnostic dilemmas in inverted papilloma. Head Neck Pathol; 2009 Sep;3(3):260-2
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Common head and neck cases in our consultation referrals: diagnostic dilemmas in inverted papilloma.
  • The most common diagnostic dilemma for pathologists referring cases for second opinion is the recognition of low grade malignancy versus benign inverted papilloma at presentation and in lesions which recur.
  • [MeSH-major] Head and Neck Neoplasms / pathology. Papilloma, Inverted / pathology
  • [MeSH-minor] Carcinoma, Squamous Cell / pathology. Diagnosis, Differential. Humans. Neoplasm Recurrence, Local / pathology. Neoplasms, Multiple Primary / pathology. Neoplasms, Second Primary / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Semin Diagn Pathol. 1996 May;13(2):113-7 [8734417.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2005 Apr;262(4):263-8 [15258811.001]
  • [Cites] Eur J Surg Oncol. 2005 Oct;31(8):905-11 [16005600.001]
  • [Cites] Acta Otolaryngol. 2006 Feb;126(2):214-8 [16428203.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2006 May;18(4):300-5 [16703747.001]
  • [Cites] Rhinology. 2006 Sep;44(3):211-5 [17020070.001]
  • [Cites] Am J Clin Oncol. 2007 Oct;30(5):560-3 [17921720.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2007 Apr;15(2):95-8 [17413409.001]
  • [Cites] J Laryngol Otol. 2007 Sep;121(9):857-64 [17319993.001]
  • [Cites] Hum Pathol. 2008 Mar;39(3):350-8 [18187185.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2008 Aug;265(8):917-22 [18231801.001]
  • [Cites] Am J Otolaryngol. 2008 Jul-Aug;29(4):230-2 [18598832.001]
  • [Cites] Clin Nucl Med. 2007 Apr;32(4):275-8 [17413572.001]
  • (PMID = 20596982.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 13
  • [Other-IDs] NLM/ PMC2811634
  •  go-up   go-down


75. Bisdas S, Baghi M, Huebner F, Mueller C, Knecht R, Vorbuchner M, Ruff J, Gstoettner W, Vogl TJ: In vivo proton MR spectroscopy of primary tumours, nodal and recurrent disease of the extracranial head and neck. Eur Radiol; 2007 Jan;17(1):251-7
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] In vivo proton MR spectroscopy of primary tumours, nodal and recurrent disease of the extracranial head and neck.
  • Benign and malignant neoplasms as well as metastatic lymph nodes of 39 patients were examined using localized single voxel magnetic resonance spectroscopy (MRS) [repetition time (TR) 1500, echo time (TE) 135) at 1.5 T.
  • The Cho/Cr ratios in all malignant neoplasms (mean: 5.2, range: 1.7-17.8) were significantly elevated relative to those in the normal muscle structures (mean: 0.9, range: 0.2-1.4), while those in the benign neoplasms were elevated (mean: 24.4, range: 1.4-59.7) with respect to those in the malignant ones.
  • The average Cho/Cr ratio in the metastatic lymph nodes was significantly higher (mean: 4.8, range: 3.3-5.6) than that for benign lymphoid hyperplasia (mean: 2.2, range: 1.0-3.0).
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Magnetic Resonance Spectroscopy. Neoplasm Recurrence, Local / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 1989 Jun;86(12):4402-6 [2734292.001]
  • [Cites] Magn Reson Med. 1993 Apr;29(4):436-40 [8385259.001]
  • [Cites] Breast Cancer Res. 2005;7(4):149-52 [15987466.001]
  • [Cites] AJNR Am J Neuroradiol. 2004 Nov-Dec;25(10):1696-704 [15569733.001]
  • [Cites] NMR Biomed. 1998 Nov;11(7):360-9 [9859942.001]
  • [Cites] AJNR Am J Neuroradiol. 1997 Jun-Jul;18(6):1057-72 [9194433.001]
  • [Cites] AJNR Am J Neuroradiol. 2000 Jun-Jul;21(6):1133-8 [10871028.001]
  • [Cites] Radiology. 1997 Sep;204(3):661-6 [9280241.001]
  • [Cites] Eur Radiol. 2005 Apr;15(4):645-52 [15627189.001]
  • [Cites] J Comput Assist Tomogr. 2004 Mar-Apr;28(2):233-46 [15091129.001]
  • [Cites] AJNR Am J Neuroradiol. 2004 Mar;25(3):484-90 [15037477.001]
  • [Cites] Am J Med. 1994 Apr;96(4):383-8 [8166160.001]
  • [Cites] NMR Biomed. 1998 Oct;11(6):266-72 [9802468.001]
  • [Cites] Technol Cancer Res Treat. 2004 Dec;3(6):557-65 [15560713.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1381-9 [12873684.001]
  • [Cites] AJNR Am J Neuroradiol. 2001 Apr;22(4):604-12 [11290466.001]
  • [Cites] AJNR Am J Neuroradiol. 2000 Nov-Dec;21(10):1930-5 [11110549.001]
  • [Cites] AJNR Am J Neuroradiol. 2000 Jan;21(1):183-93 [10669248.001]
  • [Cites] Magn Reson Med. 2001 May;45(5):765-9 [11323802.001]
  • [Cites] Invasion Metastasis. 1993;13(2):57-71 [8225853.001]
  • [Cites] Cancer Res. 2005 Apr 15;65(8):3030-4 [15833828.001]
  • (PMID = 16703309.001).
  • [ISSN] 0938-7994
  • [Journal-full-title] European radiology
  • [ISO-abbreviation] Eur Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


76. Nguyen QH, Szeto E, Mansberg R, Mansberg V: Paravertebral infection (phlegmon) demonstrated by FDG dual-head coincidence imaging in a patient with multiple malignancies. Clin Nucl Med; 2005 Apr;30(4):241-3
MedlinePlus Health Information. consumer health - Staphylococcal Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paravertebral infection (phlegmon) demonstrated by FDG dual-head coincidence imaging in a patient with multiple malignancies.
  • The scan appearance was suspicious for a localized soft tissue neoplasm.
  • Because FDG is not tumor-specific, accumulation in benign lesions may give rise to false-positive results despite a high pretest probability for malignancy.

  • MedlinePlus Health Information. consumer health - Cellulitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15764879.001).
  • [ISSN] 0363-9762
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


77. Saussez S, Mahillon V, Blaivie C, Haller A, Chantrain G, Thill MP: Aggressive pilomatrixoma of the infra-auricular area: a case report. Auris Nasus Larynx; 2005 Dec;32(4):407-10
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although pilomatrixomas are well known among dermatologists and dermatopathologists, head and neck surgeons confronted with these lesions in the infra-auricular region do not consider this benign neoplasm in the differential diagnosis.
  • Aggressive pilomatrixoma is a benign tumor of the hair matrix cells affecting mainly children.
  • [MeSH-minor] Adolescent. Diagnosis, Differential. Humans. Male. Neoplasm Staging

  • Genetic Alliance. consumer health - Pilomatrixoma.
  • MedlinePlus Health Information. consumer health - Hair Problems.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16198080.001).
  • [ISSN] 0385-8146
  • [Journal-full-title] Auris, nasus, larynx
  • [ISO-abbreviation] Auris Nasus Larynx
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 13
  •  go-up   go-down


78. Lai JC, Tsai YL: Schwannoma of the auricle. B-ENT; 2010;6(4):281-3
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Schwannoma is a benign, encapsulated, slow-growing neoplasm.
  • Approximately 25-45% of all schwannomas occur in the head and neck, whereas schwannomas of the external ear are extremely uncommon, with only nine cases reported in the English literature since the first report in 1977.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21302691.001).
  • [ISSN] 1781-782X
  • [Journal-full-title] B-ENT
  • [ISO-abbreviation] B-ENT
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


79. Smith RB, Robinson RA, Hoffman HT, Graham MM: Preoperative FDG-PET imaging to assess the malignant potential of follicular neoplasms of the thyroid. Otolaryngol Head Neck Surg; 2008 Jan;138(1):101-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: When a fine needle aspiration biopsy of a thyroid nodule suggests follicular neoplasm, surgery is required for diagnosis.
  • SUBJECTS AND METHODS: Twenty-three patients with a diagnosis of follicular neoplasm underwent presurgical FDG-PET at 60, 90, and 120 minutes after injection of fluorodeoxyglucose (F18).
  • RESULTS: There were 5 malignant conditions and 18 benign conditions identified with the standard uptake valve (SUV) ranging from 0.9 to 44.8.
  • The SUV increased in 80% of the malignant cases but in only 50% of the benign cases.
  • CONCLUSION: Despite certain patterns being suggestive of malignancy, FDG-PET can not consistently predict the malignant potential of a follicular neoplasm.
  • [MeSH-minor] Adult. Aged. Biopsy, Fine-Needle. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Staging. Prognosis. Prospective Studies. Reproducibility of Results. Thyroidectomy / methods

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18165002.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


80. Gaut AW, Jay AP, Robinson RA, Goh JP, Graham SM: Invasive glomus tumor of the nasal cavity. Am J Otolaryngol; 2005 May-Jun;26(3):207-9
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Glomus tumors are neoplasms that occur only rarely in the head and neck.
  • These tumors are usually distinguished by benign growth characteristics.
  • To our knowledge, this is the first report of an invasive glomus tumor of the head and neck.
  • [MeSH-major] Glomus Tumor / pathology. Head and Neck Neoplasms / pathology
  • [MeSH-minor] Aged. Aged, 80 and over. Female. Humans. Immunohistochemistry. Nasal Cavity. Neoplasm Invasiveness

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15858779.001).
  • [ISSN] 0196-0709
  • [Journal-full-title] American journal of otolaryngology
  • [ISO-abbreviation] Am J Otolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


81. Alves CA, Ribeiro Júnior O, Borba AM, Gouveia MM, Guimarães Júnior J, Aburad A, de Souza SC: Pleomorphic multicentric adenoma in the submandibular gland. Head Neck Pathol; 2007 Dec;1(2):178-80

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Neoplasms of salivary glands represent a small group among the diseases involving the head and neck complex.
  • In this group, the pleomorphic adenoma is the most frequent neoplasm, yet involves the submandibular gland in only 12.3% of cases.
  • This multicentric finding is of great interest, perhaps explaining the recurrence rate of this neoplasm.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Otolaryngol Head Neck Surg. 2002 Dec;128(12):1400-3 [12479728.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 2004 Jul;68(7):895-902 [15183580.001]
  • [Cites] J Oral Maxillofac Surg. 2004 Oct;62(10):1203-8 [15452806.001]
  • [Cites] Cancer. 1989 Mar 15;63(6):1219-24 [2917323.001]
  • [Cites] J Oral Maxillofac Surg. 1995 May;53(5):506-8; discussion 509 [7722716.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1996 Jan;32B(1):3-7 [8729611.001]
  • [Cites] Br J Oral Maxillofac Surg. 1996 Dec;34(6):515-9 [8971446.001]
  • [Cites] J Oral Maxillofac Surg. 1997 Sep;55(9):1011-4 [9294517.001]
  • [Cites] Int J Oral Maxillofac Surg. 2005 Jul;34(5):533-6 [16053874.001]
  • [Cites] Int J Oral Maxillofac Surg. 2006 Jul;35(7):608-12 [16540285.001]
  • (PMID = 20614272.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2807518
  • [Keywords] NOTNLM ; Benign neoplasm / Multicentric tumor / Pleomorphic adenoma / Salivary gland tumor / Submandibular gland
  •  go-up   go-down


82. Hornick JL, Fletcher CD: Cellular neurothekeoma: detailed characterization in a series of 133 cases. Am J Surg Pathol; 2007 Mar;31(3):329-40
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cellular neurothekeomas are distinctive benign cutaneous tumors of uncertain histogenesis.
  • The tumors arose most often on the upper limb (35%) or head and neck (33%).
  • In 30% of cases, neurothekeoma was suggested by the referring pathologist; the most common other diagnoses offered were plexiform fibrohistiocytic tumor, benign fibrous histiocytoma, and a low-grade sarcoma.
  • Cellular neurothekeomas have a predilection for the upper limbs and head and neck of pediatric and young adult females and rarely recur following incomplete excision.
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / analysis. Child. Child, Preschool. Diagnosis, Differential. Female. Histiocytoma, Benign Fibrous / diagnosis. Humans. Immunohistochemistry. Infant. Male. Middle Aged. Mitosis. Neoplasm Recurrence, Local. Sarcoma / diagnosis

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17325474.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


83. Seyhan T, Borman H, Bal N: Malignant eccrine spiradenoma of the scalp. J Craniofac Surg; 2008 Nov;19(6):1608-12
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Malignant eccrine spiradenoma is a rare neoplasm generally arising from long-standing benign eccrine spiradenomas; it is rarely seen on the scalp.
  • A 27-year-old woman with a malignant eccrine spiradenoma of the scalp, which had occurred 8 months after the inadequate excision of a benign eccrine spiradenoma, was treated at our hospital.
  • We report a case of a malignant eccrine spiradenoma of the scalp with cranial involvement that arose from an inadequately removed, long-standing, benign eccrine spiradenoma in a young patient.
  • [MeSH-major] Adenoma, Sweat Gland / diagnosis. Head and Neck Neoplasms / diagnosis. Neoplasm Recurrence, Local / diagnosis. Scalp / pathology. Skin Neoplasms / diagnosis
  • [MeSH-minor] Adult. Alopecia / diagnosis. Female. Follow-Up Studies. Humans. Neoplasm Invasiveness. Sentinel Lymph Node Biopsy. Skin Transplantation

  • Genetic Alliance. consumer health - Malignant eccrine spiradenoma.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19098562.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 25
  •  go-up   go-down


84. Pulvermacker B, Seroussi D, Haddad R, Mitrofanoff M: [Pilomatricoma or calcifying epithelioma of Malherbe. A pediatric review of 89 cases]. Ann Chir Plast Esthet; 2007 Feb;52(1):39-42
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Pilomatricome ou épithélioma calcifié de Malherbe : à propos d'une série de 89 cas chez l'enfant.
  • This tumor, also known as calcifying epithelioma of Malherbe, is common in the pediatric population and occurs mainly on the head and neck region.
  • It is a benign skin neoplasm usually misdiagnosed and yet the most common hair follicle tumor.
  • [MeSH-major] Hair Diseases / pathology. Head and Neck Neoplasms / pathology. Pilomatrixoma / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Hair Problems.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17030388.001).
  • [ISSN] 0294-1260
  • [Journal-full-title] Annales de chirurgie plastique et esthétique
  • [ISO-abbreviation] Ann Chir Plast Esthet
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


85. Moorthy PN, Ranganatha Reddy B, Qaiyum HA, Madhira S, Kolloju S: Management of juvenile nasopharyngeal angiofibroma: a five year retrospective study. Indian J Otolaryngol Head Neck Surg; 2010 Oct;62(4):390-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Juvenile nasopharyngeal angiofibroma is a pathologically benign yet locally aggressive and destructive vascular lesion of head and neck region typically affecting adolescent boys.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22319699.001).
  • [ISSN] 0973-7707
  • [Journal-full-title] Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
  • [ISO-abbreviation] Indian J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3266082
  • [Keywords] NOTNLM ; Angiofibroma / Nasopharynx / Neoplasm staging / Recurrence
  •  go-up   go-down


86. Folk GS, Williams SB, Foss RB, Fanburg-Smith JC: Oral and maxillofacial sclerosing epithelioid fibrosarcoma: report of five cases. Head Neck Pathol; 2007 Sep;1(1):13-20
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Approximately 59 cases of SEF have been reported, with only 12 previously described in head and neck locations.
  • The OMF Pathology Department Registry was searched for cases coded from 1990 to the present as "SEF," "fibrosarcoma not otherwise specified" or "neoplasm of uncertain histiogenesis."
  • The differential diagnosis for these tumors in this site includes sclerosing carcinoma, Ewing/PNET, osteosarcoma, osteoblastoma, and benign and malignant myoepithelial salivary gland tumors.
  • [MeSH-minor] Adult. Apoptosis. Biomarkers, Tumor / metabolism. Diagnosis, Differential. Epithelioid Cells / metabolism. Epithelioid Cells / pathology. Female. Histiocytoma, Benign Fibrous / diagnosis. Humans. Leiomyoma / diagnosis. Male. Middle Aged. Sclerosis. Solitary Fibrous Tumors / diagnosis. Young Adult

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Genet Cytogenet. 2000 Jun;119(2):127-31 [10867148.001]
  • [Cites] Cancer. 1989 Aug 15;64(4):925-31 [2545330.001]
  • [Cites] Am J Surg Pathol. 2001 Jun;25(6):699-709 [11395547.001]
  • [Cites] Am J Surg Pathol. 2002 Sep;26(9):1175-83 [12218574.001]
  • [Cites] Int J Surg Pathol. 2002 Jul;10(3):227-30 [12232581.001]
  • [Cites] J Clin Pathol. 2004 Jan;57(1):90-4 [14693846.001]
  • [Cites] Cancer Genet Cytogenet. 2004 Jul 15;152(2):136-40 [15262433.001]
  • [Cites] Virchows Arch. 2004 Oct;445(4):410-3 [15322876.001]
  • [Cites] Neurosurgery. 2000 Oct;47(4):956-9; discussion 959-60 [11014436.001]
  • [Cites] Methods Enzymol. 1990;184:357-63 [1697021.001]
  • [Cites] Am J Surg Pathol. 1995 Sep;19(9):979-93 [7661286.001]
  • [Cites] Histopathology. 1996 May;28(5):451-5 [8735721.001]
  • [Cites] J Clin Oncol. 1997 Jan;15(1):350-62 [8996162.001]
  • [Cites] Histopathology. 1998 Oct;33(4):354-60 [9822926.001]
  • [Cites] Cancer Genet Cytogenet. 1998 Dec;107(2):102-6 [9844602.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2005 Feb;114(2):87-9 [15757185.001]
  • [ErratumIn] Head Neck Pathol. 2013 Mar;7(1):103
  • (PMID = 20614275.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Other-IDs] NLM/ PMC2807507
  • [Keywords] NOTNLM ; Maxillofacial / Oral / Sarcoma / Sclerosing epithelioid fibrosarcoma
  •  go-up   go-down


87. Gaio E, Marioni G, Blandamura S, Staffieri A: Inverted papilloma involving the temporal bone and its association with squamous cell carcinoma: critical analysis of the literature. Expert Rev Anticancer Ther; 2005 Apr;5(2):391-7
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Inverted papilloma is a rare, benign neoplasm, which usually originates from the lateral nasal wall and can be locally aggressive, extending into surrounding structures.
  • [MeSH-minor] Combined Modality Therapy. Humans. Magnetic Resonance Imaging. Neoplasm Invasiveness. Neoplasm Recurrence, Local. Prognosis

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15877533.001).
  • [ISSN] 1744-8328
  • [Journal-full-title] Expert review of anticancer therapy
  • [ISO-abbreviation] Expert Rev Anticancer Ther
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 35
  •  go-up   go-down


88. Bekler H, Gokce A, Beyzadeoglu T: Chondroid syringoma of the hand: a rare localization. Handchir Mikrochir Plast Chir; 2007 Dec;39(6):430-2
Genetic Alliance. consumer health - Syringoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Chondroid syringoma is a rare benign neoplasm of the sweat glands that usually occurs in the head and neck region.
  • We describe a 18-year-old male patient with a benign chondroid syringoma that occurred at an unusual site, leading to compression symptoms of the ulnar nerve causing symptoms at the hypothenar region of the right hand.
  • [MeSH-minor] Adolescent. Biopsy. Humans. Image Enhancement. Magnetic Resonance Imaging. Male. Muscle, Skeletal / pathology. Neoplasm Invasiveness

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18058676.001).
  • [ISSN] 0722-1819
  • [Journal-full-title] Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft für Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft für Mikrochirurgie der Peripheren Nerven und Gefässe : Organ der Vereinigung der Deutschen Plastischen Chirurgen
  • [ISO-abbreviation] Handchir Mikrochir Plast Chir
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


89. Golub JS, Parikh SL, Budnick SD, Bernardino CR, DelGaudio JM: Inverted papilloma of the nasolacrimal system invading the orbit. Ophthal Plast Reconstr Surg; 2007 Mar-Apr;23(2):151-3
MedlinePlus Health Information. consumer health - Tears.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This case illustrates the importance of including inverted papilloma, a benign but invasive neoplasm, in the differential diagnosis of nasolacrimal duct obstruction.
  • [MeSH-minor] Aged. Dacryocystorhinostomy. Humans. Male. Neoplasm Invasiveness. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Eye Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17413635.001).
  • [ISSN] 0740-9303
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


90. Chen X, Yu K, Tong GX, Hood M, Storper I, Hamele-Bena D: Fine needle aspiration of pleomorphic lipoma of the neck: report of two cases. Diagn Cytopathol; 2010 Mar;38(3):184-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pleomorphic lipoma is a rare lipocytic neoplasm that most commonly occurs in the head and neck region in middle-aged to elderly men.
  • Histopathologically and cytogenetically, it has some features overlapping with other benign and malignant tumors, such as benign spindle cell lipoma, atypical lipomatous tumor, liposarcoma, and malignant fibrous histiocytoma.
  • [MeSH-major] Head and Neck Neoplasms / pathology. Lipoma / pathology. Soft Tissue Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19774616.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


91. Durden FL Jr, Moore CE, Muller S: Verrucous carcinoma of the paranasal sinuses: a case report. Ear Nose Throat J; 2010 Jul;89(7):E21-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Verrucous carcinoma is a low-grade variant of squamous cell carcinoma reported to occur in all anatomic sites in the head and neck region, most commonly the oral cavity.
  • The tumor grows locally invasive but is histologically benign and metastasizes rarely.
  • [MeSH-minor] Biopsy. Endoscopy. Humans. Male. Middle Aged. Nasal Cavity / pathology. Nasal Cavity / radiation effects. Nasal Cavity / surgery. Neoplasm Invasiveness. Neoplasm Staging. Orbital Neoplasms / pathology. Orbital Neoplasms / radiotherapy. Orbital Neoplasms / surgery. Skull / pathology. Skull / radiation effects. Skull / surgery. Skull Neoplasms / pathology. Skull Neoplasms / radiotherapy. Skull Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20628974.001).
  • [ISSN] 1942-7522
  • [Journal-full-title] Ear, nose, & throat journal
  • [ISO-abbreviation] Ear Nose Throat J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


92. Khandekar MM, Kavatkar AN, Patankar SA, Bagwan IB, Puranik SC, Deshmukh SD: FNAC of salivary gland lesions with histopathological correlation. Indian J Otolaryngol Head Neck Surg; 2006 Jul;58(3):246-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To evaluate utility of FNAC in salivary gland lesions.Back ground: Salivary gland lesions form about 2-6.5% of all head and neck neoplasms in adults.
  • Also, cytology can provide a distinction between asalivary and non salivary lesion, benign and malignant lesions so also specific and non specific inflammation.
  • RESULTS: 80% of the lesions were neoplastic (61% benign, 31% malignant) and 20% were neoplastic.
  • Pleomorphic adenoma was the most frequent benign neoplasm while mucoepidermoid carcinoma was the most frequent malignant lesion.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23120304.001).
  • [ISSN] 2231-3796
  • [Journal-full-title] Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
  • [ISO-abbreviation] Indian J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3450424
  • [Keywords] NOTNLM ; FNAC / Salivary Gland / Salivary Gland Tumours
  •  go-up   go-down


93. Stephen JK, Vaught LE, Chen KM, Sethi S, Shah V, Benninger MS, Gardner GM, Schweitzer VG, Khan M, Worsham MJ: Epigenetic events underlie the pathogenesis of sinonasal papillomas. Mod Pathol; 2007 Oct;20(10):1019-27
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Benign inverted papillomas have been reported as monoclonal but lacking common genetic alterations identified in squamous cell carcinoma of the head and neck.
  • We investigated whether epigenetic events of aberrant promoter hypermethylation in genes known to be involved in squamous head and neck cancer underlie the pathogenesis of sinonasal papillomas.
  • Epigenetic events contribute to the underlying pathogenesis of benign inverted and exophytic papillomas.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17673925.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] ENG
  • [Grant] United States / NIDCR NIH HHS / DE / R01 DE015990; United States / NIDCR NIH HHS / DE / R01 DE15990
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CDKN2B protein, human; 0 / Cyclin-Dependent Kinase Inhibitor p15; 0 / DNA, Neoplasm
  •  go-up   go-down


94. Liu F, Dong M, Zhang Y, Zhu Y, Fan Q: [Clinical pathology and anatomy features of parapharyngeal region neoplasms: a report of 69 cases]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Feb;23(3):113-4, 118
MedlinePlus Health Information. consumer health - Throat Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fifty-eight cases were benign, and 11 cases were malignancy.
  • The majority of neoplasms located in parapharyngeal regions were benign.
  • CONCLUSION: Primary parapharyngeal regions neoplasms are rare in head and neck tumors.
  • The operation type was decided by the location and the pathological type of the neoplasm.
  • [MeSH-minor] Adult. Aged. Female. Head / pathology. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Retrospective Studies. Tomography, X-Ray Computed. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19452727.001).
  • [ISSN] 1001-1781
  • [Journal-full-title] Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
  • [ISO-abbreviation] Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


95. Ang GC, Roenigk RK, Otley CC, Kim Phillips P, Weaver AL: More than 2 decades of treating atypical fibroxanthoma at mayo clinic: what have we learned from 91 patients? Dermatol Surg; 2009 May;35(5):765-72
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Atypical fibroxanthoma (AFX) typically occurs on the head and neck of elderly white men.
  • [MeSH-major] Head and Neck Neoplasms / surgery. Histiocytoma, Benign Fibrous / surgery. Hospitals, University. Mohs Surgery / methods. Skin Neoplasms / surgery. Xanthomatosis / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biopsy. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Incidence. Male. Middle Aged. Minnesota / epidemiology. Neoplasm Recurrence, Local / epidemiology. Retrospective Studies. Time Factors. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19389106.001).
  • [ISSN] 1524-4725
  • [Journal-full-title] Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • [ISO-abbreviation] Dermatol Surg
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Vandergriff TW, Reed JA, Orengo IF: An unusual presentation of atypical fibroxanthoma. Dermatol Online J; 2008;14(1):6
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Atypical fibroxanthoma (AFX) is a rare cutaneous spindle-cell neoplasm.
  • The tumor occurs most commonly in sun-damaged skin of the head and neck in elderly patients.
  • [MeSH-major] Histiocytoma, Benign Fibrous / pathology. Skin Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18319023.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Schmitz S, Weynand B, Lengelé B, Hamoir M: Solitary fibrous tumour of the soft tissue of the face: a case report. B-ENT; 2006;2(4):201-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Solitary fibrous tumour (SFT) is a rare mesenchymal neoplasm described first in the pleura.
  • Recently, SFTs have been found in various extra-serosal locations, including the head and neck region.
  • Usually, SFT is a benign tumour, although malignant variants exist.
  • The recent increase in reports of extrapleural SFT indicates that this rare tumour should be included in the differential diagnosis of soft tissue head and neck tumours.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17256410.001).
  • [ISSN] 1781-782X
  • [Journal-full-title] B-ENT
  • [ISO-abbreviation] B-ENT
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


98. Aggarwal G, Satsangi B, Shukla S, Lahoti BK, Mathur RK, Maheshwari A: Rare asymptomatic presentations of schwannomas in early adolescence: three cases with review of literature. Int J Surg; 2010;8(3):203-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Schwannoma also known as Neurilemoma is a benign neoplasm of the Schwann Cells of the neural sheath.
  • They are usually found to occur in the extremities, but can also be found in the trunk, head and neck, pelvis, and rectum.
  • [MeSH-minor] Adolescent. Back. Child. Head and Neck Neoplasms / diagnosis. Humans. Male. Pancreatic Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20167297.001).
  • [ISSN] 1743-9159
  • [Journal-full-title] International journal of surgery (London, England)
  • [ISO-abbreviation] Int J Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 23
  •  go-up   go-down


99. Wierzbicka M, Kopeć T, Szyfter W, Bem G: [Epidemiology of non-malignant salivary gland tumours based on 675 cases]. Otolaryngol Pol; 2010 Sep-Oct;64(5):281-7
MedlinePlus Health Information. consumer health - Salivary Gland Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Neoplasm of salivary glands constitutes about 3% of all tumours of head and neck.
  • This work aims at the assessment of the frequency of occurrence of non-malignant neoplasm in parotid and submandibular gland based on the material collected at the ENT Department of the Medical University in Poznan in the years 1995-2006.
  • The number of non-malignant neoplasm was 675, and the number of malignant neoplasm was 103.
  • Main aim of this work has been achieved through the execution of partial steps: the analysis of the trends in occurrence of non-malignant neoplasm in the 12-year period, the analysis of the epidemiological differences: sex, age, place of residence - town or country, duration of symptoms, diameter of the tumour at the time the patient reported for treatment, histological structures that were carried on the basis of the comparison of data collected in the two periods of time: period I--the years 1995-2000 and period II--the years 2001-2006.
  • In both periods the most frequent benign tumour was the mixed tumour (54.9% of all tumours) and constituted 60% and 54% of all tumours in the respective periods analyzed.
  • [MeSH-minor] Adult. Age Distribution. Age Factors. Aged. Female. Humans. Incidence. Male. Middle Aged. Neoplasm Staging. Poland / epidemiology. Prognosis. Salivary Gland Neoplasms / epidemiology. Salivary Gland Neoplasms / pathology. Salivary Glands / pathology. Young Adult

  • MedlinePlus Health Information. consumer health - Rural Health Concerns.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21166137.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


100. Bozzo C, Garrel R, Meloni F, Stomeo F, Crampette L: Endoscopic treatment of antrochoanal polyps. Eur Arch Otorhinolaryngol; 2007 Feb;264(2):145-50
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The antrochoanal polyp (Killian polyp) is an infrequent, benign neoplasm, which arises from the maxillary sinus to reach the ipsilateral choana.
  • [MeSH-minor] Adolescent. Adult. Child. Eosinophilia / epidemiology. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Laryngoscope. 1986 Aug;96(8):911-3 [3736304.001]
  • [Cites] Head Neck Surg. 1980 May-Jun;2(5):410-9 [7364592.001]
  • [Cites] Eur Radiol. 1997;7(4):571-2 [9204343.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1994 Sep;120(9):993-6 [8074828.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1957 Jun;66(2):306-26 [13459228.001]
  • [Cites] Acta Otorhinolaryngol Belg. 2000;54(4):473-8 [11205450.001]
  • [Cites] Acta Otolaryngol. 1995 Jul;115(4):543-7 [7572133.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1956 Sep;65(3):714-22 [13363231.001]
  • [Cites] J Laryngol Otol. 1994 Dec;108(12):1055-7 [7861080.001]
  • [Cites] Laryngoscope. 1987 Nov;97(11):1356-7 [3669848.001]
  • [Cites] Acta Otolaryngol. 1966 Jan-Feb;61(1):42-8 [5919637.001]
  • [Cites] J Laryngol Otol. 1959 May;73(5):324-34 [13665198.001]
  • [Cites] Ann Otolaryngol Chir Cervicofac. 2003 Nov;120(5):279-85 [14726847.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1990 Jul;116(7):841-3 [2363924.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1988 Nov;114(11):1270-1 [3166756.001]
  • [Cites] Laryngoscope. 1980 Sep;90(9):1488-95 [7401851.001]
  • [Cites] AMA Arch Otolaryngol. 1950 Oct;52(4):538-48 [14770693.001]
  • [Cites] Asian J Surg. 2004 Jan;27(1):22-5 [14719510.001]
  • [Cites] Laryngoscope. 2000 Sep;110(9):1581-3 [10983967.001]
  • [Cites] J Otolaryngol. 1979 Aug;8(4):344-6 [513181.001]
  • [Cites] Laryngoscope. 2003 May;113(5):874-8 [12792325.001]
  • [Cites] Rev Laryngol Otol Rhinol (Bord). 2004;125(2):133-6 [15462175.001]
  • [Cites] Proc R Soc Med. 1919;12(Laryngol Sect):104-8 [19980454.001]
  • [Cites] Laryngoscope. 2001 Oct;111(10):1774-8 [11801944.001]
  • [Cites] Endoscopy. 1986 Nov;18(6):213-8 [3792279.001]
  • (PMID = 17013627.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down






Advertisement